TWI863615B - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element - Google Patents
Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element Download PDFInfo
- Publication number
- TWI863615B TWI863615B TW112138609A TW112138609A TWI863615B TW I863615 B TWI863615 B TW I863615B TW 112138609 A TW112138609 A TW 112138609A TW 112138609 A TW112138609 A TW 112138609A TW I863615 B TWI863615 B TW I863615B
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- crystal alignment
- group
- formula
- polymer
- Prior art date
Links
Landscapes
- Liquid Crystal (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
本發明係有關一種液晶配向劑,特別是提供一種可降低畫素內對比變異度之液晶配向劑、使用此液晶配向劑所形成的液晶配向膜,以及包含此液晶配向膜的液晶顯示元件。The present invention relates to a liquid crystal alignment agent, and in particular to a liquid crystal alignment agent capable of reducing contrast variation within a pixel, a liquid crystal alignment film formed by using the liquid crystal alignment agent, and a liquid crystal display element comprising the liquid crystal alignment film.
習知之液晶顯示單元係廣泛地作為個人電腦、智慧手機、可攜式電話或電視收視機等的顯示部件。液晶顯示單元可包含如夾持於元件基板與彩色濾光片基板間之液晶層、對於液晶層施加電場之畫素電極及共通電極、控制液晶層之液晶分子的配向性之配向膜,以及切換供給至畫素電極之電子訊號的薄膜電晶體(TFT)等。就液晶分子之驅動方式而言,已知有TN(Twisted Nematic;扭曲向列型)方式與VA(Vertical Alignment;垂直對齊)方式等縱電場方式,以及IPS(In-Plane Switching;平面切換)方式與FFS(Fringe Field Switching;邊緣場切換)方式等橫電場方式。Liquid crystal display units are widely used as display components for personal computers, smart phones, portable phones, or television sets. Liquid crystal display units may include a liquid crystal layer sandwiched between a device substrate and a color filter substrate, a pixel electrode and a common electrode for applying an electric field to the liquid crystal layer, an alignment film for controlling the alignment of liquid crystal molecules in the liquid crystal layer, and a thin film transistor (TFT) for switching the electronic signal supplied to the pixel electrode. As for the driving method of liquid crystal molecules, longitudinal electric field methods such as TN (Twisted Nematic) method and VA (Vertical Alignment) method, and transverse electric field methods such as IPS (In-Plane Switching) method and FFS (Fringe Field Switching) method are known.
目前,工業上最普及的液晶配向膜係對已形成在電極基板上由聚醯胺酸及/或其經醯亞胺化獲得之聚醯亞胺所構成之膜表面,以綿、尼龍或聚酯等布沿一方向進行摩擦處理所製得。摩擦處理係簡便且生產率高之工業常用方法。但是,伴隨液晶顯示元件之高性能化、高精細化與大型化,配向膜表面因摩擦處理所產生之灰塵、機械力與靜電而形成傷痕,進而導致配向處理面內之不均勻性等各種問題產生。作為替代摩擦處理之配向處理方法,已知有藉由照射經偏光之放射線來賦予液晶配向能力之光配向法。針對光配向法,日本特開專利平9-297313號公報已揭露利用光異構化反應者、利用光交聯反應者或利用光分解反應者等。At present, the most popular liquid crystal alignment film in the industry is made by rubbing the surface of a film composed of polyamide and/or polyimide obtained by imidization formed on an electrode substrate in one direction with a cloth such as cotton, nylon or polyester. Rubbing treatment is a simple and highly productive industrial method. However, with the high performance, high precision and large-scale liquid crystal display elements, the surface of the alignment film is scratched by dust, mechanical force and static electricity generated by the friction treatment, which leads to various problems such as unevenness in the alignment treatment surface. As an alignment treatment method instead of friction treatment, a photoalignment method is known to impart alignment ability to liquid crystals by irradiating polarized radiation. Regarding the photo-alignment method, Japanese Patent Publication No. 9-297313 discloses the use of a photoisomerization reaction, a photocrosslinking reaction, or a photodecomposition reaction.
然而,含有利用光配向法所製得之習知液晶配向膜,以液晶顯示元件實施黑顯示時,畫素內對比變異度偏大,進而導致畫面內的明亮度會出現變異,有顯示品質下降的顧慮。However, when a liquid crystal display element using a conventional liquid crystal alignment film produced by a photo-alignment method is used to display black, the contrast variation within the pixel is relatively large, which in turn causes the brightness within the screen to vary, and there is a concern that the display quality will be reduced.
本發明之目的在於提供得以有效降低畫素內對比變異度之液晶配向膜,與為了獲得該液晶配向膜之液晶配向劑,以及使用了該液晶配向膜之液晶顯示元件。The purpose of the present invention is to provide a liquid crystal alignment film that can effectively reduce contrast variation within a pixel, a liquid crystal alignment agent for obtaining the liquid crystal alignment film, and a liquid crystal display element using the liquid crystal alignment film.
本案發明人為了達成上述課題努力研究,結果發現含有特定結構之聚合物之液晶配向劑所形成之液晶配向膜,對於達成上述目的極有效,乃完成本發明。The inventors of this case have made great efforts to achieve the above-mentioned goal and have found that a liquid crystal alignment film formed by a liquid crystal alignment agent containing a polymer with a specific structure is very effective in achieving the above-mentioned purpose, thus completing the present invention.
有鑑於此,本發明之一態樣是在提供一種液晶配向劑,其包含聚合物(A)。利用此液晶配向劑所形成之液晶配向膜可有效降低液晶顯示元件的畫素內對比變異度。In view of this, one aspect of the present invention is to provide a liquid crystal alignment agent, which includes a polymer (A). The liquid crystal alignment film formed by the liquid crystal alignment agent can effectively reduce the contrast variation within the pixel of the liquid crystal display element.
本發明之另一態樣是在提供一種液晶配向膜,其係利用上述的液晶配向劑所形成。Another aspect of the present invention is to provide a liquid crystal alignment film, which is formed by using the above-mentioned liquid crystal alignment agent.
本發明之又一態樣是在提供一種液晶顯示單元,其包含前述之液晶配向膜,而具有較低的畫素內對比變異度。Another aspect of the present invention is to provide a liquid crystal display unit, which includes the aforementioned liquid crystal alignment film and has a lower intra-pixel contrast variation.
根據本發明之上述態樣,提出一種液晶配向劑。本發明之液晶配向劑含有聚合物(A)。本發明之液晶配向劑的較佳實施態樣可列舉為含有聚合物(A)及有機溶劑的液晶配向劑。另外,本發明之液晶配向劑亦可含有聚合物(A)以外之聚合物(如後述之聚合物(B))。According to the above-mentioned aspects of the present invention, a liquid crystal alignment agent is proposed. The liquid crystal alignment agent of the present invention contains a polymer (A). A preferred embodiment of the liquid crystal alignment agent of the present invention can be listed as a liquid crystal alignment agent containing a polymer (A) and an organic solvent. In addition, the liquid crystal alignment agent of the present invention may also contain a polymer other than the polymer (A) (such as the polymer (B) described later).
聚合物(A)Polymer (A)
本發明之聚合物(A)可選自於由四羧酸衍生物組份(a1)及二胺組份(a2)所反應獲得之聚醯亞胺前驅物,以及聚醯亞胺前驅物之醯亞胺化聚合物所組成之群組中的至少一種聚合物。舉例而言,聚合物(A)可例如包含具有聚醯胺酸及聚醯胺酸酯等醯亞胺前驅物結構之聚醯亞胺前驅物。其中,所述之二胺組份(a2)可包含如下式(A21)所示之二胺化合物(a2-1)。 (A21) The polymer (A) of the present invention can be selected from at least one polymer in the group consisting of a polyimide precursor obtained by reacting a tetracarboxylic acid derivative component (a1) and a diamine component (a2), and an imidized polymer of a polyimide precursor. For example, the polymer (A) can include a polyimide precursor having an imide precursor structure such as polyamic acid and polyamic acid ester. The diamine component (a2) can include a diamine compound (a2-1) shown in the following formula (A21). (A21)
於式(A21)中,Y 11代表碳數為1至10之烴基;且n與m分別獨立地代表0至3。 In formula (A21), Y 11 represents a alkyl group having 1 to 10 carbon atoms; and n and m each independently represent 0 to 3.
四羧酸衍生物組份(a1)Tetracarboxylic acid derivative component (a1)
前述與二胺組份(a2)反應之四羧酸衍生物組份(a1)除可使用四羧酸二酐化合物外,亦可使用四羧酸二鹵化物、四羧酸二烷基酯,或四羧酸二烷基酯二鹵化物等之四羧酸二酐衍生物。四羧酸衍生物組份(a1)可單獨使用一種四羧酸二酐化合物或其衍生物,也可混合複數種組合使用。The tetracarboxylic acid derivative component (a1) that reacts with the diamine component (a2) may be a tetracarboxylic acid dianhydride compound, or a tetracarboxylic acid dianhydride derivative such as a tetracarboxylic acid dihalide, a tetracarboxylic acid dialkyl ester, or a tetracarboxylic acid dialkyl ester dihalide. The tetracarboxylic acid derivative component (a1) may be a single tetracarboxylic acid dianhydride compound or a derivative thereof, or may be a mixture of a plurality of such tetracarboxylic acid dianhydride compounds.
本發明之四羧酸衍生物組份(a1)可包含如式(A11)所示之脂環族四羧酸二酐化合物(a1-1)與其他四羧酸二酐化合物(a1-2)。The tetracarboxylic acid derivative component (a1) of the present invention may include an alicyclic tetracarboxylic dianhydride compound (a1-1) represented by formula (A11) and other tetracarboxylic dianhydride compounds (a1-2).
脂環族四羧酸二酐化合物(a1-1)Alicyclic tetracarboxylic dianhydride compound (a1-1)
用以反應獲得聚合物(A)之四羧酸衍生物組份(a1)可包含如下式(A11)所示之脂環族四羧酸二酐化合物(a1-1)或其衍生物。式(A11)所示之脂環族四羧酸二酐化合物(a1-1)或其衍生物可由單獨一種四羧酸二酐化合物或其衍生物所構成,也可由複數種四羧酸二酐化合物或其衍生物所構成。於本發明中,式(A11)所示之脂環族四羧酸二酐化合物(a1-1)可例如將包含鍵結於脂環族結構之至少一個羧基在內而將四個羧基進行分子內脫水所獲得之酸二酐。惟,此四個羧基均未鍵結於芳香環。或者,可無須僅由脂環族結構所構成,其一部分也可具有鏈狀烴結構或芳香環結構。芳香族四羧酸二酐可例如係將包含鍵結於芳香環之至少一個羧基在內之四個羧基進行分子內脫水所獲得之酸二酐。惟,其無須僅由芳香環結構所構成,其一部分也可具有鏈狀烴結構或脂環族結構。非環脂肪族四羧酸二酐可例如係將鍵結於鏈狀烴結構之四個羧基進行分子內脫水所獲得之酸二酐。惟,其無須僅由鏈狀烴結構所構成,其一部分也可具有脂環族結構或芳香環結構。 (A11) The tetracarboxylic acid derivative component (a1) used for the reaction to obtain the polymer (A) may include an alicyclic tetracarboxylic dianhydride compound (a1-1) or a derivative thereof as shown in the following formula (A11). The alicyclic tetracarboxylic dianhydride compound (a1-1) or a derivative thereof as shown in the formula (A11) may be composed of a single tetracarboxylic dianhydride compound or a derivative thereof, or may be composed of a plurality of tetracarboxylic dianhydride compounds or derivatives thereof. In the present invention, the alicyclic tetracarboxylic dianhydride compound (a1-1) as shown in the formula (A11) may be, for example, an acid dianhydride obtained by intramolecular dehydration of four carboxyl groups including at least one carboxyl group bonded to an alicyclic structure. However, none of the four carboxyl groups are bonded to an aromatic ring. Alternatively, it is not necessary to be composed of only alicyclic structures, and a part of it may have a chain hydrocarbon structure or an aromatic ring structure. Aromatic tetracarboxylic dianhydride may be, for example, an acid dianhydride obtained by intramolecular dehydration of four carboxyl groups including at least one carboxyl group bonded to an aromatic ring. However, it is not necessary to be composed of only an aromatic ring structure, and a part of it may have a chain hydrocarbon structure or an alicyclic structure. Non-cyclic aliphatic tetracarboxylic dianhydride may be, for example, an acid dianhydride obtained by intramolecular dehydration of four carboxyl groups bonded to a chain hydrocarbon structure. However, it is not necessary to be composed of only alicyclic hydrocarbon structures, and a part of it may have alicyclic structures or an aromatic ring structure. (A11)
於式(A11)中,X 1可選自於如下式(A11-1)至式(A11-7)所示之結構所組成的群組中之至少一者,且「*」代表鍵結位置。 (A11-1) (A11-2) (A11-3) (A11-4) (A11-5) (A11-6) (A11-7) In formula (A11), X1 can be selected from at least one of the group consisting of the structures shown in formula (A11-1) to formula (A11-7) below, and "*" represents a bonding position. (A11-1) (A11-2) (A11-3) (A11-4) (A11-5) (A11-6) (A11-7)
於式(A11-1)中,X 11、X 12、X 13與X 14分別獨立地代表氫原子、鹵素原子、碳數為1至6之烷基、碳數為2至6之烯基、碳數為2至6之炔基、碳數為1至6且含有氟原子的一價有機基,或苯基。於式(A11-7)中,X 15與X 16分別獨立地代表氫原子或甲基。 In formula (A11-1), X11 , X12 , X13 and X14 independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group having 1 to 6 carbon atoms and containing a fluorine atom, or a phenyl group. In formula (A11-7), X15 and X16 independently represent a hydrogen atom or a methyl group.
在一些實施例中,X 1可代表如下式(A11-1-1)至(A11-1-6)所示之結構。 (A11-1-1) (A11-1-2) (A11-1-3) (A11-1-4) (A11-1-5) (A11-1-6) In some embodiments, X1 can represent the structures shown in the following formulas (A11-1-1) to (A11-1-6). (A11-1-1) (A11-1-2) (A11-1-3) (A11-1-4) (A11-1-5) (A11-1-6)
較佳地,X 1代表式(A11-1-1)所示之結構。當X 1代表式(A11-1-1)所示之結構,含有其所形成之液晶配向膜的液晶顯示單元具有更低之畫素內對比變異度。 Preferably, X1 represents a structure represented by formula (A11-1-1). When X1 represents a structure represented by formula (A11-1-1), a liquid crystal display unit including a liquid crystal alignment film formed therefrom has a lower intra-pixel contrast variation.
基於四羧酸衍生物組份(a1)的總使用量為100莫耳,式(A11)所示之脂環族四羧酸二酐化合物(a1-1)的使用量為30莫耳至100莫耳,較佳為40莫耳至100莫耳,且更佳為50莫耳至100莫耳。Based on the total usage amount of the tetracarboxylic acid derivative component (a1) being 100 mol, the usage amount of the alicyclic tetracarboxylic dianhydride compound (a1-1) represented by formula (A11) is 30 mol to 100 mol, preferably 40 mol to 100 mol, and more preferably 50 mol to 100 mol.
其他四羧酸二酐化合物(a1-2)Other tetracarboxylic dianhydride compounds (a1-2)
其他四羧酸二酐化合物(a1-2)可包含如下式(A12)所示之四羧酸二酐化合物及其衍生物。 (A12) Other tetracarboxylic dianhydride compounds (a1-2) may include tetracarboxylic dianhydride compounds represented by the following formula (A12) and derivatives thereof. (A12)
於式(A12)中,X 1'可代表如下式(A12-1)至式(A12-32)所示之結構,其中「*」代表鍵結位置。 (A12-1) (A12-2) (A12-3) (A12-4) (A12-5) (A12-6) (A12-7) (A12-8) (A12-9) (A12-10) (A12-11) (A12-12) (A12-13) (A12-14) (A12-15) (A12-16) (A12-17) (A12-18) (A12-19) (A12-20) (A12-21) (A12-22) (A12-23) (A12-24) (A12-25) (A12-26) (A12-27) (A12-28) (A12-29) (A12-30) (A12-31) (A12-32) In formula (A12), X 1 ′ may represent a structure as shown in the following formula (A12-1) to formula (A12-32), wherein “*” represents a bonding position. (A12-1) (A12-2) (A12-3) (A12-4) (A12-5) (A12-6) (A12-7) (A12-8) (A12-9) (A12-10) (A12-11) (A12-12) (A12-13) (A12-14) (A12-15) (A12-16) (A12-17) (A12-18) (A12-19) (A12-20) (A12-21) (A12-22) (A12-23) (A12-24) (A12-25) (A12-26) (A12-27) (A12-28) (A12-29) (A12-30) (A12-31) (A12-32)
於式(A12-5)和式(A12-6)中,X 11'及X 12'分別獨立地代表單鍵、-O-、-CO-、-COO-、伸苯基、磺醯基或醯胺基,且於式(A12-6)中,複數個X 12'可彼此相同或不同。式(A12-5)之a1代表0或1之整數。式(A12-6)之a1代表0或1之整數。於式(A12-14)中,X 13'分別獨立地代表氫原子、鹵素原子、碳數為1至6之烷基、碳數為2至6之烯基、碳數為2至6之炔基、含有氟原子且碳數為1至6之一價有機基,或苯基,且複數個X 13'可彼此相同或不同。基於液晶配向性之觀點,X 13'較佳代表氫原子、鹵素原子、甲基或乙基,且更佳代表氫原子或甲基。 In formula (A12-5) and formula (A12-6), X 11 ' and X 12 ' each independently represent a single bond, -O-, -CO-, -COO-, a phenylene group, a sulfonyl group or an amide group, and in formula (A12-6), a plurality of X 12 ' may be the same as or different from each other. a1 in formula (A12-5) represents an integer of 0 or 1. a1 in formula (A12-6) represents an integer of 0 or 1. In formula (A12-14), X 13 ' each independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group containing a fluorine atom and having 1 to 6 carbon atoms, or a phenyl group, and a plurality of X 13 ' may be the same as or different from each other. From the viewpoint of liquid crystal alignment, X 13 ′ preferably represents a hydrogen atom, a halogen atom, a methyl group or an ethyl group, and more preferably represents a hydrogen atom or a methyl group.
在一些具體例中,前述之式(A12-5)與式(A12-6)可包含但不限於如下所示之結構。 In some specific examples, the aforementioned formula (A12-5) and formula (A12-6) may include but are not limited to the structures shown below.
前述之其他四羧酸二酐化合物(a1-2)可單獨一種使用或混合複數種使用。The aforementioned other tetracarboxylic dianhydride compounds (a1-2) may be used alone or in combination of two or more.
基於四羧酸衍生物組份(a1)的總使用量為100莫耳,其他四羧酸二酐化合物(a1-2)的使用量可為0莫耳至70莫耳,較佳為0莫耳至60莫耳,且更佳為0莫耳至50莫耳。Based on the total usage of the tetracarboxylic acid derivative component (a1) being 100 mol, the usage of the other tetracarboxylic dianhydride compound (a1-2) may be 0 mol to 70 mol, preferably 0 mol to 60 mol, and more preferably 0 mol to 50 mol.
二胺組份(a2)Diamine component (a2)
本發明之二胺組份(a2)可包含二胺化合物(a2-1)、二胺化合物(a2-2)、二胺化合物(a2-3)、二胺化合物(a2-4)與其他二胺化合物(a2-5)。The diamine component (a2) of the present invention may include a diamine compound (a2-1), a diamine compound (a2-2), a diamine compound (a2-3), a diamine compound (a2-4) and other diamine compounds (a2-5).
二胺化合物(a2-1)Diamine compound (a2-1)
本發明之二胺組份(a2)包含如下式(A21)所示之二胺化合物(a2-1)。 (A21) The diamine component (a2) of the present invention comprises a diamine compound (a2-1) represented by the following formula (A21). (A21)
於式(A21)中,Y 11代表碳數為1至10之烴基;且n與m分別獨立地代表0至3。 In formula (A21), Y 11 represents a alkyl group having 1 to 10 carbon atoms; and n and m each independently represent 0 to 3.
基於合成與配向性之觀點,式(A21)所示之二胺化合物(a2-1)較佳可例如包含如下式(A21')所示之二胺化合物。進一步而言,式(A21)中兩端與胺基鍵結之苯環上的氫原子可以被取代,如苯環的1至2個氫原子被取代為鹵素、碳數為1至3之烷基、碳數為1至3之烷氧基、碳數為1至3之氟代烷基,或者碳數為1至3之氟烷氧基。 (A21') From the viewpoint of synthesis and orientation, the diamine compound (a2-1) represented by formula (A21) may preferably include a diamine compound represented by the following formula (A21'). Further, the hydrogen atoms on the benzene rings bonded to the amino groups at both ends in formula (A21) may be substituted, such as 1 to 2 hydrogen atoms on the benzene rings are substituted with halogen, alkyl having 1 to 3 carbon atoms, alkoxy having 1 to 3 carbon atoms, fluoroalkyl having 1 to 3 carbon atoms, or fluoroalkoxy having 1 to 3 carbon atoms. (A21')
於式(A21')中,Y 11、m與n之定義分別如前所述。 In formula (A21'), Y 11 , m and n are defined as above.
前述Y 11所代表之烴基係選自由脂肪族鏈狀烴基、脂肪族環式烴基及芳香族烴基所組成之群組的至少一種。 The alkyl group represented by Y 11 is at least one selected from the group consisting of an aliphatic chain alkyl group, an aliphatic cyclic alkyl group and an aromatic alkyl group.
前述之脂肪族鏈狀烴基係指在主鏈中不含有環狀結構,而僅由鏈狀結構構成的直鏈狀或支鏈狀的烴基,其可為飽和的,亦可為不飽和的。前述之脂肪族環式烴基係指含有脂環狀結構之烴基,且不含有芳環結構的烴基。然而,脂肪族環式烴基不必僅由脂環狀結構之烴基所構成,其中一些可更具有鏈狀結構。The aforementioned aliphatic chain alkyl refers to a straight chain or branched chain alkyl that does not contain a ring structure in the main chain and is composed only of a chain structure, which may be saturated or unsaturated. The aforementioned aliphatic cyclic alkyl refers to a alkyl group that contains an alicyclic structure and does not contain an aromatic ring structure. However, the aliphatic cyclic alkyl group does not have to be composed only of alicyclic alkyl groups, and some of them may have a chain structure.
於碳數為1至10之脂肪族鏈狀烴基的具體例中,此些烴基可包含飽和及不飽和之脂肪族鏈狀烴基。飽和之脂肪族鏈狀烴基可為飽和之直鏈或支鏈烴基。飽和之直鏈烴基可例如包含但不限於亞甲基、伸乙基、丙二基、丁二基、戊二基、己二基、庚二基、辛二基、壬二基或癸二基。飽和之支鏈烴基可例如包含但不限於第二丁烷二基、第三丁烷二基、異戊烷二基、第三戊烷二基、異辛烷二基、2-乙基己烷二基、第三辛烷二基、異壬烷二基或異癸烷二基。In the specific example of an aliphatic chain alkyl group having a carbon number of 1 to 10, these alkyl groups may include saturated and unsaturated aliphatic chain alkyl groups. The saturated aliphatic chain alkyl group may be a saturated straight chain or branched chain alkyl group. The saturated straight chain alkyl group may include, but is not limited to, a methylene group, an ethylene group, a propanediyl group, a butanediyl group, a pentanediyl group, a hexanediyl group, a heptanediyl group, an octanediyl group, a nonanediyl group, or a decanediyl group. The saturated branched chain alkyl group may include, but is not limited to, a second butanediyl group, a third butanediyl group, an isopentanediyl group, a third pentanediyl group, an isooctanediyl group, a 2-ethylhexanediyl group, a third octanediyl group, an isononanediyl group, or an isodecanediyl group.
不飽和之脂肪族鏈狀烴基可包含具有不飽和鍵(如烯鍵及/或炔鍵)之不飽和鏈狀烴基,並且此些基團亦可為直鏈或支鏈。舉例而言,不飽和之脂肪族鏈狀烴基可包含但不限於乙烯二基、庚烯二基、2-丁烯二基、3-甲基-4-乙基-1-己烯二基、丙炔二基、2-己炔二基、3-甲基-1-戊炔二基、3-乙基-1-庚炔二基或3,5-二甲基-4-己烯-1-庚炔二基。此外,碳數為3至10的脂環烴基的具體例可包含但不限於環丁烷二基、環戊烷二基、環己烷二基、環庚烷二基,且前述環上的氫原子可被取代。The unsaturated aliphatic chain hydrocarbon group may include an unsaturated chain hydrocarbon group having an unsaturated bond (such as an olefinic bond and/or an alkynyl bond), and these groups may also be straight chains or branched chains. For example, the unsaturated aliphatic chain hydrocarbon group may include but is not limited to ethylenediyl, heptenediyl, 2-butenediyl, 3-methyl-4-ethyl-1-hexenediyl, propynediyl, 2-hexynediyl, 3-methyl-1-pentynediyl, 3-ethyl-1-heptynediyl or 3,5-dimethyl-4-hexene-1-heptynediyl. In addition, specific examples of the alicyclic hydrocarbon group having 3 to 10 carbon atoms include, but are not limited to, cyclobutanediyl, cyclopentanediyl, cyclohexanediyl, and cycloheptanediyl, and the hydrogen atoms on the aforementioned rings may be substituted.
芳香族烴基可例如包含但不限於苯環、萘環、四氫萘環、薁環、茚環、芴環、蒽環、菲環或非那烯(Phenalene)環。The aromatic hydrocarbon group may include, but is not limited to, a benzene ring, a naphthyl ring, a tetrahydronaphthyl ring, an azulene ring, an indene ring, a fluorene ring, an anthracene ring, a phenanthrene ring or a phenalene ring.
於式(A21)中,Y 11較佳可代表碳數為1至5之脂肪族鏈狀烴基,且更佳代表碳數為1至3之飽和直鏈烴基。其中,當式(A21)中之Y 11代表碳數為1至5之脂肪族鏈狀烴基時,所製得之液晶配向劑將使得所形成的液晶顯示元件具有較低的畫素內對比變異度。當Y 11代表碳數為1至3之飽和直鏈烴基時,所形成的液晶顯示元件之畫素內對比變異度可更進一步降低。 In formula (A21), Y 11 preferably represents an aliphatic chain hydrocarbon group having 1 to 5 carbon atoms, and more preferably represents a saturated linear hydrocarbon group having 1 to 3 carbon atoms. When Y 11 in formula (A21) represents an aliphatic chain hydrocarbon group having 1 to 5 carbon atoms, the liquid crystal alignment agent prepared will allow the formed liquid crystal display element to have a lower intra-pixel contrast variability. When Y 11 represents a saturated linear hydrocarbon group having 1 to 3 carbon atoms, the intra-pixel contrast variability of the formed liquid crystal display element can be further reduced.
在一些具體例中,式(A21)所示之二胺化合物(a2-1)可包含但不限於如下式(A21-1)至式(A21-10)所示之二胺化合物。 (A21-1) (A21-2) (A21-3) (A21-4) (A21-5) (A21-6) (A21-7) (A21-8) (A21-9) (A21-10) In some specific examples, the diamine compound (a2-1) represented by formula (A21) may include but is not limited to the diamine compounds represented by the following formulas (A21-1) to (A21-10). (A21-1) (A21-2) (A21-3) (A21-4) (A21-5) (A21-6) (A21-7) (A21-8) (A21-9) (A21-10)
前述之二胺化合物(a2-1)可單獨一種使用或混合複數種使用。The aforementioned diamine compound (a2-1) may be used alone or in combination of two or more.
基於二胺組份(a2)之總使用量為100莫耳,二胺化合物(a2-1)的使用量可為1莫耳至95莫耳,較佳為5莫耳至90莫耳,且更佳為10莫耳至85莫耳。Based on the total usage amount of the diamine component (a2) being 100 mol, the usage amount of the diamine compound (a2-1) may be 1 mol to 95 mol, preferably 5 mol to 90 mol, and more preferably 10 mol to 85 mol.
若二胺組份(a2)不包含如式(A21)所示之二胺化合物(a2-1)時,所製得之液晶配向劑將使得所形成的液晶顯示元件具有過高的畫素內對比變異度。If the diamine component (a2) does not contain the diamine compound (a2-1) represented by formula (A21), the resulting liquid crystal alignment agent will cause the formed liquid crystal display element to have excessively high intra-pixel contrast variation.
以下詳述二胺化合物(a2-1)之主要合成方法,以下所述之方法僅為舉例說明,本案之二胺化合物(a2-1)的製備不受限於此。The main synthesis method of the diamine compound (a2-1) is described in detail below. The method described below is only for illustration, and the preparation of the diamine compound (a2-1) of the present invention is not limited thereto.
舉例而言,如式(A21-8)所示之二胺化合物可如下示之反應式(S21-1)藉由還原二硝基化合物,以將硝基轉換為胺基所製得。 (S21-1) For example, the diamine compound represented by formula (A21-8) can be prepared by reducing a dinitro compound to convert the nitro group into an amino group according to the reaction formula (S21-1) shown below. (S21-1)
二硝基化合物之還原方法並無特殊限制,其可例如使用鈀-碳、氧化鉑、雷氏鎳(Raney nickel)、鉑黑、銠-氧化鋁或硫化鉑碳等做為觸媒,於如乙酸乙酯、甲苯、四氫呋喃、二噁烷及/或醇類的溶劑中,藉由氫氣、肼及氯化氫進行還原之方法。亦可依需要使用高壓釜,於加壓下進行。另一方面,於苯環或飽和烴基之氫原子的取代基結構含有不飽和鍵之情況下,當使用鈀-碳或硫化鉑碳時,取代基之不飽和鍵可能會被還原成飽和鍵。因此,較佳為使用還原鐵、錫或氯化錫等之過渡金屬做為觸媒。The reduction method of the dinitro compound is not particularly limited. For example, palladium-carbon, platinum oxide, Raney nickel, platinum black, rhodium-alumina or platinum sulfide-carbon can be used as a catalyst, and the reduction can be carried out by hydrogen, hydrazine and hydrogen chloride in a solvent such as ethyl acetate, toluene, tetrahydrofuran, dioxane and/or alcohol. It can also be carried out under pressure using an autoclave as needed. On the other hand, when the substituent structure of the hydrogen atom of the benzene ring or saturated alkyl contains an unsaturated bond, when palladium-carbon or platinum sulfide-carbon is used, the unsaturated bond of the substituent may be reduced to a saturated bond. Therefore, it is preferred to use a transition metal such as reduced iron, tin or tin chloride as a catalyst.
前述之二硝基化合物可如下示之反應式(S21-2)來反應合成,其可藉由使市售之脂肪族或芳香族二元醇衍生物與被離去基(X)取代的硝基苯反應,得到二硝基化合物。離去基(X)較佳可例如為氟原子、氯原子、溴原子、碘原子、甲苯磺酸酯(-OTs)或甲磺酸酯(-OMs)。 (S21-2) The aforementioned dinitro compound can be synthesized by reaction as shown in the following reaction formula (S21-2), which can be obtained by reacting a commercially available aliphatic or aromatic diol derivative with nitrobenzene substituted with a leaving group (X). The leaving group (X) is preferably, for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a toluene sulfonate (-OTs) or a mesylate (-OMs). (S21-2)
反應式(S21-2)所示之反應可在鹼存在下進行。所使用之鹼只要能夠合成,則無特殊限定,可列舉碳酸鉀、碳酸鈉、碳酸銫、烷氧化鈉、烷氧化鉀、氫氧化鈉、氫氧化鉀及/或氫化鈉等之無機鹼;以及吡啶、二甲基胺基吡啶、三甲胺、三乙胺及/或三丁胺等之有機鹼。依情況,當合併使用如二亞苄基丙酮鈀或二苯基膦基二茂鐵鈀之鈀觸媒或銅觸媒時,可提高產率。基於容易合成之觀點,較佳為使用吡啶之方法,但此方法以外的方法亦能夠合成製得二硝基化合物,因此二硝基化合物的合成方法並無特別限定。The reaction shown in reaction formula (S21-2) can be carried out in the presence of a base. The base used is not particularly limited as long as it can be synthesized, and examples thereof include inorganic bases such as potassium carbonate, sodium carbonate, cesium carbonate, sodium alkoxide, potassium alkoxide, sodium hydroxide, potassium hydroxide and/or sodium hydroxide; and organic bases such as pyridine, dimethylaminopyridine, trimethylamine, triethylamine and/or tributylamine. Depending on the situation, when a palladium catalyst or a copper catalyst such as dibenzylideneacetone palladium or diphenylphosphinoferrocene palladium is used in combination, the yield can be increased. From the viewpoint of easy synthesis, the method using pyridine is preferred, but methods other than this method can also synthesize the dinitro compound, so the method for synthesizing the dinitro compound is not particularly limited.
二胺化合物(a2-2)Diamine compound (a2-2)
本發明之二胺組分(a2)可包含如下式(A22)所示之二胺化合物(a2-2)。 (A22) The diamine component (a2) of the present invention may include a diamine compound (a2-2) represented by the following formula (A22). (A22)
於式(A22)中,R 1、R 2與R 3分別獨立地代表苯環或吡啶環之二價有機基團;R 4代表氧原子或硫原子;R 5代表碳數為1至30的二價鏈狀烴基或碳數為3至30的脂環烴基;R 6及R 7分別獨立地代表單鍵、氧原子、硫原子或-NR 8-,其中R 6及R 7之至少一者代表氧原子、硫原子或-NR 8-,且R 8代表氫原子或甲基;當R 1、R 2與R 3之任一者為吡啶環時,R 6及R 7不代表單鍵。當二胺組分(a2)包含如式(A22)所示之二胺化合物(a2-2)時,所製得之液晶配向劑將使得所形成之液晶顯示元件具有較低的畫素內對比變異度。 In formula (A22), R 1 , R 2 and R 3 each independently represent a divalent organic group of a benzene ring or a pyridine ring; R 4 represents an oxygen atom or a sulfur atom; R 5 represents a divalent chain hydrocarbon group having 1 to 30 carbon atoms or an alicyclic hydrocarbon group having 3 to 30 carbon atoms; R 6 and R 7 each independently represent a single bond, an oxygen atom, a sulfur atom or -NR 8 -, wherein at least one of R 6 and R 7 represents an oxygen atom, a sulfur atom or -NR 8 -, and R 8 represents a hydrogen atom or a methyl group; when any one of R 1 , R 2 and R 3 is a pyridine ring, R 6 and R 7 do not represent a single bond. When the diamine component (a2) comprises a diamine compound (a2-2) as represented by formula (A22), the resulting liquid crystal alignment agent will allow the formed liquid crystal display element to have a lower intra-pixel contrast variation.
較佳地,R 5代表碳數為1至30的二價鏈狀烴基;更佳地,R 5代表碳數為1至11的二價鏈狀烴基;尤佳地,R 5代表碳數為1至11的直鏈伸烷基。當R 5代表前述之取代基時,使得所製得之含有液晶配向劑的液晶顯示元件具有更低之畫素內對比變異度。 Preferably, R 5 represents a divalent chain alkyl group having a carbon number of 1 to 30; more preferably, R 5 represents a divalent chain alkyl group having a carbon number of 1 to 11; and particularly preferably, R 5 represents a linear alkyl group having a carbon number of 1 to 11. When R 5 represents the aforementioned substituent, the resulting liquid crystal display element containing the liquid crystal alignment agent has a lower intra-pixel contrast variation.
前述R 5代表之鏈狀烴基係指在主鏈中不含有環狀結構,而僅由鏈狀結構構成的直鏈狀或支鏈狀的烴基,可為飽和的,亦可為不飽和的。前述R 5代表之脂環烴基係指含有脂環狀結構之烴基,且不含有芳環結構的烴基。然而,其不必僅由脂環狀結構之烴基所構成,其中一些可更具有鏈狀結構。 The chain alkyl represented by R 5 above refers to a straight chain or branched chain alkyl group that does not contain a ring structure in the main chain and is composed only of a chain structure, which may be saturated or unsaturated. The alicyclic alkyl group represented by R 5 above refers to a alkyl group that contains an alicyclic structure and does not contain an aromatic ring structure. However, it is not necessary to be composed only of alicyclic alkyl groups, and some of them may have a chain structure.
於碳數為1至30鏈狀烴基的具體例中,此些烴基可包含飽和及不飽和之鏈狀烴基。飽和之鏈狀烴基可為飽和之直鏈或支鏈烴基。飽和之直鏈烴基可如亞甲基、伸乙基、丙二基、丁二基、戊二基、己二基、庚二基、辛二基、壬二基、癸二基、十二烷二基、十四烷二基、十五烷二基、十六烷二基及十八烷二基。飽和之支鏈烴基可如第二丁烷二基、第三丁烷二基、異戊烷二基、第三戊烷二基、異辛烷二基、2-乙基己烷二基、第三辛烷二基、異壬烷二基及異癸烷二基。In the specific example of the chain alkyl group having 1 to 30 carbon atoms, these alkyl groups may include saturated and unsaturated chain alkyl groups. The saturated chain alkyl group may be a saturated straight chain or branched chain alkyl group. The saturated straight chain alkyl group may be, for example, methylene, ethylidene, propanediyl, butanediyl, pentanediyl, hexanediyl, heptanediyl, octanediyl, nonanediyl, decanediyl, dodecanediyl, tetradecanediyl, pentadecanediyl, hexadecanediyl and octadecanediyl. The saturated branched chain alkyl group may be, for example, sec-butanediyl, tert-butanediyl, isopentanediyl, tert-pentanediyl, isooctanediyl, 2-ethylhexanediyl, tert-octanediyl, isononanediyl and isodecanediyl.
不飽和之鏈狀烴基可包含具有不飽和鍵(如烯鍵及/或炔鍵)之不飽和鏈狀烴基,並且此些基團亦可為直鏈或支鏈。例如:乙烯二基、庚烯二基、2-丁烯二基、3-甲基-4-乙基-1-己烯二基、丙炔二基、2-己炔二基、3-甲基-1-戊炔二基、3-乙基-1-庚炔二基及3,5-二甲基-4-己烯-1-庚炔二基。此外,碳數為3至30的脂環烴基的具體例可包含環丁烷二基、環戊烷二基、環己烷二基、環庚烷二基及其環上的氫原子被取代之基團。The unsaturated chain hydrocarbon group may include unsaturated chain hydrocarbon groups having unsaturated bonds (such as olefinic bonds and/or acetylene bonds), and these groups may also be straight chains or branched chains. For example: ethylenediyl, heptenediyl, 2-butenediyl, 3-methyl-4-ethyl-1-hexenediyl, propynediyl, 2-hexynediyl, 3-methyl-1-pentynediyl, 3-ethyl-1-heptynediyl and 3,5-dimethyl-4-hexene-1-heptynediyl. In addition, specific examples of alicyclic hydrocarbon groups having 3 to 30 carbon atoms may include cyclobutanediyl, cyclopentanediyl, cyclohexanediyl, cycloheptanediyl and groups in which hydrogen atoms on the rings are substituted.
在一些具體例中,如式(A22)所示之二胺化合物(a2-2)可包含但不限於下列之具體二胺化合物。 (A22-1) (A22-2) (A22-3) (A22-4) (A22-5) (A22-6) (A22-7) (A22-8) (A22-9) (A22-10) (A22-11) (A22-12) (A22-13) (A22-14) (A22-15) (A22-16) (A22-17) (A22-18) (A22-19) (A22-20) (A22-21) (A22-22) (A22-23) (A22-24) (A22-25) (A22-26) (A22-27) (A22-28) (A22-29) (A22-30) (A22-31) (A22-32) (A22-33) (A22-34) (A22-35) (A22-36) (A22-37) (A22-38) In some specific examples, the diamine compound (a2-2) represented by formula (A22) may include but is not limited to the following specific diamine compounds. (A22-1) (A22-2) (A22-3) (A22-4) (A22-5) (A22-6) (A22-7) (A22-8) (A22-9) (A22-10) (A22-11) (A22-12) (A22-13) (A22-14) (A22-15) (A22-16) (A22-17) (A22-18) (A22-19) (A22-20) (A22-21) (A22-22) (A22-23) (A22-24) (A22-25) (A22-26) (A22-27) (A22-28) (A22-29) (A22-30) (A22-31) (A22-32) (A22-33) (A22-34) (A22-35) (A22-36) (A22-37) (A22-38)
於式(A22-1)、式(A22-3)、式(A22-5)、式(A22-6)、式(A22-8)、式(A22-14)及式(A22-24)至式(A22-34)中,Ra代表氫原子或甲基,但並不僅限於此,亦可代表其他基團。In formula (A22-1), formula (A22-3), formula (A22-5), formula (A22-6), formula (A22-8), formula (A22-14), and formula (A22-24) to formula (A22-34), Ra represents a hydrogen atom or a methyl group, but is not limited thereto and may also represent other groups.
前述之二胺化合物(a2-2)可單獨一種使用或混合複數種使用。The aforementioned diamine compound (a2-2) may be used alone or in combination of two or more.
從充分得到聚合物(A)(如聚醯胺酸(PAA))的合成中,基於二胺組分(a2)的使用量為100莫耳,如式(A22)所示之二胺化合物(a2-2)的使用量為5莫耳至99莫耳,較佳可為7莫耳至95莫耳,且更佳可為10莫耳至40莫耳。In the synthesis of a fully obtained polymer (A) (such as polyamine (PAA)), based on the usage of the diamine component (a2) being 100 mol, the usage of the diamine compound (a2-2) shown in formula (A22) is 5 mol to 99 mol, preferably 7 mol to 95 mol, and more preferably 10 mol to 40 mol.
以下詳述二胺化合物(a2-2)之主要合成方法,以下所述之方法僅為舉例說明,本案之二胺化合物(a2-2)的製備不受限於此。The main synthesis method of the diamine compound (a2-2) is described in detail below. The method described below is only for illustration, and the preparation of the diamine compound (a2-2) of the present invention is not limited thereto.
舉例而言,如式(A22-7)所示之二胺化合物可如下示之反應式(S22-1)藉由還原二硝基化合物,以將硝基轉換為胺基所製得。 (S22-1) For example, the diamine compound represented by formula (A22-7) can be prepared by reducing a dinitro compound to convert the nitro group into an amino group according to the reaction formula (S22-1) shown below. (S22-1)
二硝基化合物之還原方法並無特殊限制,可例示使用鈀-碳、氧化鉑、雷氏鎳(Raney nickel)、鉑黑、銠-氧化鋁、硫化鉑碳等做為觸媒,於如乙酸乙酯、甲苯、四氫呋喃、二噁烷及醇類之溶劑中,藉由氫氣、肼及氯化氫進行還原之方法。亦可依需要使用高壓釜,於加壓下進行。另一方面,於取代苯環或飽和烴基之氫原子的取代基結構中含有不飽和鍵之情況下,當使用鈀-碳或硫化鉑碳時,不飽和鍵可能會被還原成飽和鍵。因此,較佳為使用還原鐵、錫或氯化錫之過渡金屬做為觸媒的還原條件。The reduction method of the dinitro compound is not particularly limited. Examples include palladium-carbon, platinum oxide, Raney nickel, platinum black, rhodium-alumina, platinum sulfide-carbon, etc. as catalysts, and reduction by hydrogen, hydrazine, and hydrogen chloride in solvents such as ethyl acetate, toluene, tetrahydrofuran, dioxane, and alcohols. It is also possible to use an autoclave under pressure as needed. On the other hand, when the substituent structure of the hydrogen atom of the substituted benzene ring or saturated alkyl contains an unsaturated bond, when palladium-carbon or platinum sulfide-carbon is used, the unsaturated bond may be reduced to a saturated bond. Therefore, it is preferred to use a transition metal such as reduced iron, tin or tin chloride as a reducing condition for the catalyst.
前述之二硝基化合物可如下示之反應式(S22-2)來反應合成,其可藉由使市售之二苯基醚衍生物、苯氧基吡啶衍生物或二吡啶醚衍生物與被離去基(X)取代的硝基苯或硝基吡啶反應,得到二硝基化合物。離去基(X)較佳可例如為氟原子、氯原子、溴原子、碘原子、甲苯磺酸酯(-OTs)或甲磺酸酯(-OMs)。 (S22-2) The aforementioned dinitro compound can be synthesized by reaction as shown in the following reaction formula (S22-2), which can be obtained by reacting a commercially available diphenyl ether derivative, a phenoxypyridine derivative or a bipyridine ether derivative with nitrobenzene or nitropyridine substituted with a leaving group (X). The leaving group (X) is preferably, for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a toluene sulfonate (-OTs) or a mesylate (-OMs). (S22-2)
反應式(S21-2)所示之反應可在鹼存在下進行。所使用之鹼只要能夠合成,則無特殊限定,可列舉碳酸鉀、碳酸鈉、碳酸銫、烷氧化鈉、烷氧化鉀、氫氧化鈉、氫氧化鉀及/或氫化鈉等之無機鹼;以及吡啶、二甲基胺基吡啶、三甲胺、三乙胺及/或三丁胺等之有機鹼。依情況,當合併使用如二亞苄基丙酮鈀或二苯基膦基二茂鐵鈀之鈀觸媒或銅觸媒時,可提高產率。由容易合成之觀點來看,較佳為使用碳酸鉀之方法,但此方法以外亦能夠合成,因此二硝基化合物的合成方法並無特別限定。The reaction shown in reaction formula (S21-2) can be carried out in the presence of a base. The base used is not particularly limited as long as it can be synthesized, and examples thereof include inorganic bases such as potassium carbonate, sodium carbonate, cesium carbonate, sodium alkoxide, potassium alkoxide, sodium hydroxide, potassium hydroxide and/or sodium hydroxide; and organic bases such as pyridine, dimethylaminopyridine, trimethylamine, triethylamine and/or tributylamine. Depending on the situation, when a palladium catalyst or a copper catalyst such as dibenzylideneacetone palladium or diphenylphosphinoferrocene palladium is used in combination, the yield can be increased. From the viewpoint of easy synthesis, the method using potassium carbonate is preferred, but other methods are also possible, and therefore the method for synthesizing the dinitro compound is not particularly limited.
二胺化合物(a2-3)Diamine compound (a2-3)
本發明之二胺組份(a2)可包含二胺化合物(a2-3),且二胺化合物(a2-3)可包含如下式(A23-1)或式(A23-2)所示之二胺化合物。 (A23-1) (A23-2) The diamine component (a2) of the present invention may include a diamine compound (a2-3), and the diamine compound (a2-3) may include a diamine compound represented by the following formula (A23-1) or formula (A23-2). (A23-1) (A23-2)
於式(A23-1)中,Y 31代表如下式(A23-3)所示之二價有機基團。複數個Y 32分別獨立地代表氫原子或碳數為1至6之烷基。於式(A23-2)中,複數個Y 33分別獨立地代表如下式(A23-3')所示之二價有機基團。 (A23-3) (A23-3') In formula (A23-1), Y 31 represents a divalent organic group as shown in formula (A23-3). A plurality of Y 32s each independently represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. In formula (A23-2), a plurality of Y 33s each independently represents a divalent organic group as shown in formula (A23-3'). (A23-3) (A23-3')
於式(A23-3)中,Ar分別獨立地代表二價之苯環、聯苯結構或萘環,且苯環、聯苯結構或萘環之氫原子可被一價取代基團所取代或未被取代;Y 31'代表-(CH 2) n-,n代表2至18之整數,且-(CH 2) n-中的至少一個-CH 2-可被-O-、-C(=O)-或-O-C(=O)-所取代或未被取代;p1代表0或1之整數;「*」代表鍵結位置。 In formula (A23-3), Ar independently represents a divalent benzene ring, a biphenyl structure or a naphthyl ring, and the hydrogen atom of the benzene ring, the biphenyl structure or the naphthyl ring may be substituted by a monovalent substituent group or may not be substituted; Y 31 ' represents -(CH 2 ) n -, n represents an integer from 2 to 18, and at least one -CH 2 - in -(CH 2 ) n - may be substituted by -O-, -C(=O)- or -OC(=O)- or may not be substituted; p1 represents an integer of 0 or 1; "*" represents a bonding position.
於式(A23-3')中,Ar'分別獨立地代表二價之苯環或聯苯結構,且苯環或聯苯結構之氫原子可被一價取代基團所取代或未被取代;Y 33'代表-(CH 2) n-,n代表2至18之整數,且-(CH 2) n-中的至少一個-CH 2-可被-O-、-C(=O)-或-O-C(=O)-所取代或未被取代;p2代表0或1之整數;「*」代表鍵結位置。 In formula (A23-3'), Ar' independently represents a divalent benzene ring or a biphenyl structure, and the hydrogen atom of the benzene ring or the biphenyl structure may be substituted by a monovalent substituent group or may not be substituted; Y 33 ' represents -(CH 2 ) n -, n represents an integer from 2 to 18, and at least one -CH 2 - in -(CH 2 ) n - may be substituted by -O-, -C(=O)- or -OC(=O)- or may not be substituted; p2 represents an integer of 0 or 1; "*" represents a bonding position.
前述苯環、聯苯結構、或萘環之一價取代基團可例如為鹵素原子、碳數為1至10之烷基、碳數為2至10之烯基、碳數為1至10之烷氧基、碳數為1至10之氟烷基、碳數為2至10之氟烯基、碳數為1至10之氟烷氧基、羧基、羥基、碳數為1至10之烷氧基羰基、氰基或硝基等。The monovalent substituent of the aforementioned benzene ring, biphenyl structure, or naphthyl ring may be, for example, a halogen atom, an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a fluoroalkyl group having 1 to 10 carbon atoms, a fluoroalkenyl group having 2 to 10 carbon atoms, a fluoroalkoxy group having 1 to 10 carbon atoms, a carboxyl group, a hydroxyl group, an alkoxycarbonyl group having 1 to 10 carbon atoms, a cyano group, or a nitro group.
基於提高液晶配向性之觀點,式(A23-3)所示之二價有機基團較佳可包含如下式(A23-3-1)至式(A23-3-16)所示之基團,其中「*」代表鍵結位置。 (A23-3-1) (A23-3-2) (A23-3-3) (A23-3-4) (A23-3-5) (A23-3-6) (A23-3-7) (A23-3-8) (A23-3-9) (A23-3-10) (A23-3-11) (A23-3-12) (A23-3-13) (A23-3-14) (A23-3-15) (A23-3-16) From the perspective of improving the liquid crystal alignment, the divalent organic group represented by formula (A23-3) may preferably include groups represented by the following formulas (A23-3-1) to (A23-3-16), wherein "*" represents the bonding position. (A23-3-1) (A23-3-2) (A23-3-3) (A23-3-4) (A23-3-5) (A23-3-6) (A23-3-7) (A23-3-8) (A23-3-9) (A23-3-10) (A23-3-11) (A23-3-12) (A23-3-13) (A23-3-14) (A23-3-15) (A23-3-16)
於式(A23-3-14)中,複數個m分別獨立地代表1至3之整數。In formula (A23-3-14), the multiple m's independently represent integers from 1 to 3.
基於提高液晶配向性之觀點,式(A23-3')所示之二價有機基團較佳可包含如式(A23-3-7)至式(A23-3-16)所示之基團。From the viewpoint of improving the liquid crystal alignment, the divalent organic group represented by formula (A23-3') may preferably include groups represented by formulas (A23-3-7) to (A23-3-16).
當二胺化合物(a2-3)包含複數個如式(A23-1)所示之二胺化合物時,其較佳為式(A23-1)中之Y 31代表式(A23-3-1)至式(A23-3-14)的二胺化合物與式(A23-1)中之Y 31代表式(A23-3-15)至式(A23-3-16)的二胺化合物之組合。 When the diamine compound (a2-3) contains a plurality of diamine compounds as shown in formula (A23-1), it is preferably a combination of a diamine compound in which Y 31 in formula (A23-1) represents a diamine compound of formula (A23-3-1) to formula (A23-3-14) and a diamine compound in which Y 31 in formula (A23-1) represents a diamine compound of formula (A23-3-15) to formula (A23-3-16).
在一些具體例中,如前述式(A23-2)所示之二胺化合物可包含但不限於如下式(A23-2-1)至式(A23-2-5)所示之二胺化合物。 (A23-2-1) (A23-2-2) (A23-2-3) (A23-2-4) (A23-2-5) In some specific examples, the diamine compound represented by the aforementioned formula (A23-2) may include but is not limited to the diamine compounds represented by the following formulas (A23-2-1) to (A23-2-5). (A23-2-1) (A23-2-2) (A23-2-3) (A23-2-4) (A23-2-5)
前述之二胺化合物(a2-3)可單獨一種使用或混合複數種使用。The aforementioned diamine compounds (a2-3) may be used alone or in combination of two or more.
基於二胺組份(a2)之總使用量為100莫耳,二胺化合物(a2-3)的使用量可為5莫耳至99莫耳,較佳為10莫耳至90莫耳,且更佳為15莫耳至87莫耳。Based on the total usage amount of the diamine component (a2) being 100 mol, the usage amount of the diamine compound (a2-3) may be 5 mol to 99 mol, preferably 10 mol to 90 mol, and more preferably 15 mol to 87 mol.
二胺化合物(a2-4)Diamine compound (a2-4)
基於提高液晶顯示元件之電壓保持率的觀點,聚合物(A)之分子結構可選擇性地具有-N(D)-之基團(其中,D代表胺甲酸酯系保護基)。具有-N(D)-之基團的聚合物(A)可藉由將具有-N(D)-之基團的單體作為反應原料的至少一部分之方法,或者藉由將其作為後述封端劑的方法來獲得。在一些具體例中,該具有-N(D)-基團之單體可例如為具有-N(D)-基團的二胺化合物(a2-4)。舉例而言,所述之胺甲酸酯系保護基可包含但不限於第三丁氧基羰基、9-茀基甲氧基羰基。From the viewpoint of improving the voltage retention rate of the liquid crystal display element, the molecular structure of the polymer (A) may selectively have an -N(D)- group (wherein D represents a carbamate-based protective group). The polymer (A) having an -N(D)- group may be obtained by using a monomer having an -N(D)- group as at least a part of the reaction raw material, or by using it as a capping agent as described later. In some specific examples, the monomer having an -N(D)- group may be, for example, a diamine compound (a2-4) having an -N(D)- group. For example, the carbamate-based protective group may include, but is not limited to, tert-butyloxycarbonyl and 9-fluorenylmethoxycarbonyl.
較佳地,具有-N(D)-基團的二胺化合物(a2-4)包含具有至少一個苯環等芳香基的二胺化合物。更佳地,具有-N(D)-基團的二胺化合物(a2-4)包含具有至少一個苯環等芳香基,且取代基(D)以外之殘基係碳數為6至30的二胺化合物。在一些具體例中,具有-N(D)-基團的二胺化合物(a2-4)可包含但不限於如下式(A24-1)至式(A24-10)所示之二胺化合物。 (A24-1) (A24-2) (A24-3) (A24-4) (A24-5) (A24-6) (A24-7) (A24-8) (A24-9) (A24-10) Preferably, the diamine compound (a2-4) having an -N(D)- group includes a diamine compound having at least one aromatic group such as a benzene ring. More preferably, the diamine compound (a2-4) having an -N(D)- group includes a diamine compound having at least one aromatic group such as a benzene ring, and the residue other than the substituent (D) has a carbon number of 6 to 30. In some specific examples, the diamine compound (a2-4) having an -N(D)- group may include but is not limited to the diamine compounds shown in the following formulas (A24-1) to (A24-10). (A24-1) (A24-2) (A24-3) (A24-4) (A24-5) (A24-6) (A24-7) (A24-8) (A24-9) (A24-10)
前述之二胺化合物(a2-4)可單獨一種使用或混合複數種使用。The aforementioned diamine compounds (a2-4) may be used alone or in combination of two or more.
基於二胺組份(a2)之總使用量為100莫耳,二胺化合物(a2-4)的使用量可為5莫耳至99莫耳,較佳為10莫耳至52莫耳,且更佳為15莫耳至37莫耳。Based on the total usage amount of the diamine component (a2) being 100 mol, the usage amount of the diamine compound (a2-4) may be 5 mol to 99 mol, preferably 10 mol to 52 mol, and more preferably 15 mol to 37 mol.
其他二胺化合物(a2-5)Other diamine compounds (a2-5)
除前述如式(A21)所示之二胺化合物(a2-1)、如式(A22)所示之二胺化合物(a2-2)、二胺化合物(a2-3)與二胺化合物(a2-4)外,用以獲得聚合物(A)之二胺組份(a2)可選擇性地包含其他二胺化合物(a2-5)。舉例而言,其他二胺化合物(a2-5)可包含但不限於:4,4'-二胺基偶氮苯或如下式(A25-1)至式(A25-3)所示之二胺化合物等具有光配向性基之二胺化合物;2,4-二胺基苯酚、3,5-二胺基苯酚、3,5-二胺基苯甲醇、2,4-二胺基苯甲醇或4,6-二胺基間苯二酚;2,4-二胺基苯甲酸、2,5-二胺基苯甲酸、3,5-二胺基苯甲酸或如下式(A25-4)至式(A25-7)所示之二胺化合物等具有羧基之二胺化合物;3,3'-二胺基二苯基甲烷、4,4'-二胺基二苯基甲烷、3,4'-二胺基二苯基甲烷、4,4'-二胺基二苯基酮、1,4-雙(4-胺基苄基)苯、4,4'-二胺基二苯醚、1-(4-胺基苯基)-1,3,3-三甲基-1H-二氫茚-5-胺或1-(4-胺基苯基)-2,3-二氫-1,3,3-三甲基-1H-茚-6-胺;如下式(A25-8)至式(A25-10)所示之二胺化合物等具有脲鍵之二胺化合物;如下式(A25-11)至式(A25-13)所示之具有醯胺鍵之二胺化合物;甲基丙烯酸2-(2,4-二胺基苯氧基)乙基或2,4-二胺基-N,N-二烯丙基苯胺等末端有光聚合性基之二胺化合物;具有矽氧烷鍵的二胺,例如 3-雙(3-氨基丙基)-四甲基二矽氧烷;如下式(A25-14)至式(A25-15)所示之二胺化合物等具㗁唑啉結構之二胺化合物。 (A25-1) (A25-2) (A25-3) (A25-4) (A25-5) (A25-6) (A25-7) (A25-8) (A25-9) (A25-10) (A25-11) (A25-12) (A25-13) (A25-14) (A25-15) In addition to the aforementioned diamine compound (a2-1) as represented by formula (A21), the diamine compound (a2-2) as represented by formula (A22), the diamine compound (a2-3) and the diamine compound (a2-4), the diamine component (a2) used to obtain the polymer (A) may optionally include other diamine compounds (a2-5). For example, other diamine compounds (a2-5) may include but are not limited to: 4,4'-diaminoazobenzene or diamine compounds represented by the following formulas (A25-1) to (A25-3) and other diamine compounds having a photo-alignment group; 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol or 4,6-diaminoresorcinol; 2,4-diaminoazobenzene; Benzoic acid, 2,5-diaminobenzoic acid, 3,5-diaminobenzoic acid or a diamine compound having a carboxyl group such as a diamine compound represented by the following formula (A25-4) to (A25-7); 3,3'-diaminodiphenylmethane, 4,4'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ketone, 1,4-bis(4-aminobenzyl)benzene, 4,4'-diaminodiphenyl Aminodiphenyl ether, 1-(4-aminophenyl)-1,3,3-trimethyl-1H-dihydroindene-5-amine or 1-(4-aminophenyl)-2,3-dihydro-1,3,3-trimethyl-1H-indene-6-amine; diamine compounds having a urea bond such as diamine compounds represented by the following formulas (A25-8) to (A25-10); diamine compounds having a urea bond such as diamine compounds represented by the following formulas (A25-11) to (A25-13); Diamine compounds having an amide bond; diamine compounds having a photopolymerizable group at the end such as 2-(2,4-diaminophenoxy)ethyl methacrylate or 2,4-diamino-N,N-diallylaniline; diamine compounds having a siloxane bond, such as 3-bis(3-aminopropyl)-tetramethyldisiloxane; diamine compounds having an oxazoline structure such as diamine compounds represented by the following formulas (A25-14) to (A25-15). (A25-1) (A25-2) (A25-3) (A25-4) (A25-5) (A25-6) (A25-7) (A25-8) (A25-9) (A25-10) (A25-11) (A25-12) (A25-13) (A25-14) (A25-15)
於式(A25-4)中,Y 51表示單鍵、-CH 2-、-C 2H 4-、-C(CH 3) 2-、-CF 2-、-C(CF 3) 2-、-O-、-CO-、-NH-、-N(CH 3)-、-CONH-、-NHCO-、-CH 2O-、-OCH 2-、-COO-、-OCO-、-CON(CH 3)-或-N(CH 3)CO-;m1及m2分別獨立地代表0至4之整數,且(m1+m2)代表1至4之整數。於式(A25-5)中,m3及m4分別獨立地代表1至5之整數。於式(A25-6)中,Y 52表示碳數為1至5之直鏈或支鏈烷基;m5表示1至5之整數。於式(A25-7)中,Y 53及Y 54分別獨立地代表單鍵、-CH 2-、-C 2H 4-、-C(CH 3) 2-、-CF 2-、-C(CF 3) 2-、-O-、-CO-、-NH-、-N(CH 3)-、-CONH-、-NHCO-、-CH 2O-、-OCH 2-、-COO-、-OCO-、-CON(CH 3)-或-N(CH 3)CO-;m6表示1至4之整數。 In formula (A25-4), Y51 represents a single bond, -CH2- , -C2H4- , -C( CH3 ) 2- , -CF2- , -C( CF3 ) 2- , -O-, -CO- , -NH-, -N ( CH3 )-, -CONH-, -NHCO-, -CH2O-, -OCH2- , -COO-, -OCO-, -CON( CH3 )- or -N( CH3 )CO-; m1 and m2 each independently represent an integer of 0 to 4, and (m1+m2) represents an integer of 1 to 4. In formula (A25-5), m3 and m4 each independently represent an integer of 1 to 5. In formula (A25-6), Y52 represents a linear or branched alkyl group having 1 to 5 carbon atoms; m5 represents an integer from 1 to 5. In formula (A25-7) , Y53 and Y54 each independently represent a single bond, -CH2- , -C2H4- , -C( CH3 ) 2- , -CF2-, -C( CF3 ) 2- , -O-, -CO- , -NH-, -N ( CH3 )-, -CONH-, -NHCO-, -CH2O-, -OCH2- , -COO-, -OCO-, -CON( CH3 )- or -N( CH3 )CO-; m6 represents an integer from 1 to 4.
前述之其他二胺化合物(a2-5)可單獨一種使用或混合複數種使用。The other diamine compounds (a2-5) mentioned above may be used alone or in combination of two or more.
基於二胺組份(a2)之總使用量為100莫耳,其他二胺化合物(a2-5)的使用量可為5莫耳至99莫耳,較佳為10莫耳至52莫耳,且更佳為15莫耳至37莫耳。Based on the total usage amount of the diamine component (a2) being 100 mol, the usage amount of the other diamine compound (a2-5) may be 5 mol to 99 mol, preferably 10 mol to 52 mol, and more preferably 15 mol to 37 mol.
聚合物(B)Polymer (B)
除前述之聚合物(A)外,本發明之液晶配向劑也可選擇性地含有選自於由使用四羧酸衍生物組份(b1)及二胺組份(b2)獲得之聚醯亞胺前驅物,以及此聚醯亞胺前驅物之醯亞胺化聚合物(即聚醯亞胺)所組成之群組中的聚合物(B)。舉例而言,聚合物(B)可例如包含但不限於選自於由使用四羧酸衍生物組份(b1)及不含上述特定二胺化合物(如式(A21)所示之二胺化合物(a2-1))之二胺組份(b2)反應獲得之聚醯亞胺前驅物及此聚醯亞胺前驅物之醯亞胺化物(即聚醯亞胺)所組成之群組中的至少一種聚合物。上述聚醯亞胺前驅物之具體例可例如包含聚醯胺酸或聚醯胺酸酯等。所述之聚合物(B)可單獨一種使用,也可混合複數種使用。In addition to the aforementioned polymer (A), the liquid crystal alignment agent of the present invention may also optionally contain a polymer (B) selected from the group consisting of a polyimide precursor obtained by using a tetracarboxylic acid derivative component (b1) and a diamine component (b2), and an imidized polymer (i.e., polyimide) of the polyimide precursor. For example, the polymer (B) may include, but is not limited to, at least one polymer selected from the group consisting of a polyimide precursor obtained by reacting a tetracarboxylic acid derivative component (b1) and a diamine component (b2) that does not contain the aforementioned specific diamine compound (e.g., the diamine compound (a2-1) shown in formula (A21)) and an imidized product (i.e., polyimide) of the polyimide precursor. Specific examples of the polyimide precursor include polyamic acid or polyamic acid ester, etc. The polymer (B) may be used alone or in combination of two or more.
聚合物(A)與聚合物(B)之用量比例(即[聚合物(A)]/[聚合物(B)]的質量比)可為10/90至90/10,較佳為20/80至90/10,且更佳為20/80至80/20。The usage ratio of polymer (A) to polymer (B) (i.e., the mass ratio of [polymer (A)]/[polymer (B)]) may be 10/90 to 90/10, preferably 20/80 to 90/10, and more preferably 20/80 to 80/20.
四羧酸衍生物組份(b1)Tetracarboxylic acid derivative component (b1)
用以獲得聚合物(B)之四羧酸衍生物組份(b1)可例如包含但不限於非環族脂肪族四羧酸二酐化合物、脂環族四羧酸二酐化合物、芳香族四羧酸二酐化合物,或此些化合物之衍生物。非環族脂肪族四羧酸二酐化合物、脂環族四羧酸二酐化合物與芳香族四羧酸二酐化合物之具體例可例如包含前述聚合物(A)所例示之四羧酸二酐化合物。較佳地,四羧酸衍生物組份(b1)可包含如上式(A11)所示之脂環族四羧酸二酐或其衍生物(a1-1),或者如上式(A12)所示且X 1'代表式(A12-1)至式(A12-6)所示之結構的四羧酸二酐化合物或其衍生物。所述之四羧酸衍生物組份(b1)可單獨一種使用或混合複數種使用。 The tetracarboxylic acid derivative component (b1) used to obtain the polymer (B) may include, for example, but not limited to, a non-cyclic aliphatic tetracarboxylic acid dianhydride compound, alicyclic tetracarboxylic acid dianhydride compound, aromatic tetracarboxylic acid dianhydride compound, or derivatives of these compounds. Specific examples of the non-cyclic aliphatic tetracarboxylic acid dianhydride compound, alicyclic tetracarboxylic acid dianhydride compound, and aromatic tetracarboxylic acid dianhydride compound may include, for example, the tetracarboxylic acid dianhydride compound exemplified for the aforementioned polymer (A). Preferably, the tetracarboxylic acid derivative component (b1) may include an alicyclic tetracarboxylic acid dianhydride or a derivative thereof (a1-1) as shown in the above formula (A11), or a tetracarboxylic acid dianhydride compound or a derivative thereof as shown in the above formula (A12) and X 1 ' represents a structure shown in formula (A12-1) to formula (A12-6). The tetracarboxylic acid derivative component (b1) may be used alone or in combination of a plurality of them.
四羧酸衍生物組份(b1)較佳包含如上式(A12)所示且X 1'代表下式(A12-33)所示之結構的四羧酸二酐化合物(後述將其稱之為四羧酸二酐化合物(b1-1))。 (A12-33) The tetracarboxylic acid derivative component (b1) preferably comprises a tetracarboxylic dianhydride compound represented by the above formula (A12) and wherein X 1 ′ represents a structure represented by the following formula (A12-33) (hereinafter referred to as a tetracarboxylic dianhydride compound (b1-1)). (A12-33)
於該式(A12-33)中,Z 11代表單鍵;且「*」代表鍵結位置。 In the formula (A12-33), Z 11 represents a single bond; and "*" represents a bonding position.
前述之四羧酸二酐化合物(b1-1)可單獨一種使用或混合複數種使用。The aforementioned tetracarboxylic dianhydride compound (b1-1) may be used alone or in combination of two or more.
更佳地,四羧酸衍生物組份(b1)包含如下式(B11)所示之四羧酸二酐化合物。 (B11) More preferably, the tetracarboxylic acid derivative component (b1) comprises a tetracarboxylic dianhydride compound represented by the following formula (B11). (B11)
基於四羧酸衍生物組份(b1)之總使用量為100莫耳,四羧酸二酐化合物(b1-1)的使用量可為30莫耳至100莫耳,較佳為40莫耳至100莫耳,且更佳為50莫耳至100莫耳。Based on the total usage of the tetracarboxylic acid derivative component (b1) being 100 mol, the usage of the tetracarboxylic dianhydride compound (b1-1) may be 30 mol to 100 mol, preferably 40 mol to 100 mol, and more preferably 50 mol to 100 mol.
二胺組份(b2)Diamine component (b2)
用以獲得聚合物(B)之二胺組份(b2)可例如包含但不限於前述之二胺組份(a2),或者具有選自於由含氮原子之雜環、二級胺基與三級胺基所構成之群組中之至少一種含氮原子結構的二胺化合物(後述將其稱之為二胺化合物(b2-1)),但二胺組份(b2)不包含前述之二胺化合物(a2-1)。The diamine component (b2) used to obtain the polymer (B) may include, for example, but is not limited to, the aforementioned diamine component (a2), or a diamine compound having at least one nitrogen-containing atom structure selected from the group consisting of a nitrogen-containing heterocyclic ring, a diamine group, and a tertiary amine group (hereinafter referred to as a diamine compound (b2-1)), but the diamine component (b2) does not include the aforementioned diamine compound (a2-1).
所述之二胺組份(b2)可單獨一種使用或混合複數種使用。The diamine component (b2) may be used alone or in combination of two or more.
二胺化合物(b2-1)Diamine compound (b2-1)
具有上述特定之含氮原子結構之二胺化合物(b2-1)可具有含氮原子之雜環,例如:吡咯、咪唑、吡唑、三唑、吡啶、嘧啶、嗒 、吡 、吲哚、苯并咪唑、嘌呤、喹啉、異喹啉、㖠啶、喹㗁啉、呔 、三 、咔唑、吖啶、哌啶、哌 、吡咯啶或六亞甲基亞胺等。其中,吡啶、嘧啶、吡 、哌啶、哌 、喹啉、咔唑或吖啶為較佳。 The diamine compound (b2-1) having the above-mentioned specific nitrogen-containing atom structure may have a nitrogen-containing heterocyclic ring, such as pyrrole, imidazole, pyrazole, triazole, pyridine, pyrimidine, tantalum, , pyridine , indole, benzimidazole, purine, quinoline, isoquinoline, oxadiazole, quinazoline, tether ,three , carbazole, acridine, piperidine, piperidine , pyrrolidine or hexamethyleneimine, etc. Among them, pyridine, pyrimidine, pyrrolidine , piperidine, piperidine , quinoline, carbazole or acridine is preferred.
具有上述特定之含氮原子結構之二胺化合物(b2-1)可包含如下式(B21)所示之二級胺基及三級胺基。 (B21) The diamine compound (b2-1) having the above-mentioned specific nitrogen atom-containing structure may include a diamine group and a tertiary amine group as represented by the following formula (B21). (B21)
於式(B21)中,Z代表氫原子或碳數為1至10之烷基、環烷基或芳基;「*」代表鍵結烴基的鍵結位置。In formula (B21), Z represents a hydrogen atom or an alkyl group, a cycloalkyl group or an aryl group having 1 to 10 carbon atoms; "*" represents the bonding position to the alkyl group.
前述Z所代表之烷基可例如包含但不限於甲基、乙基或丙基;所代表之環烷基可例如包含但不限於環己基;所代表之芳基可例如包含但不限於苯基或甲苯基。Z較佳為氫原子或甲基。The alkyl represented by Z may include, but not limited to, methyl, ethyl or propyl; the cycloalkyl represented by Z may include, but not limited to, cyclohexyl; the aryl represented by Z may include, but not limited to, phenyl or tolyl. Z is preferably a hydrogen atom or a methyl group.
具有上述特定之含氮原子結構的二胺化合物(b2-1)之具體例可例如包含:2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、3,6-二胺基咔唑、N-甲基-3,6-二胺基咔唑、1,4-雙-(4-胺基苯基)-哌 、3,6-二胺基吖啶、N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基咔唑、如下式(B21-1)至式(B21-8)所示之二胺化合物,或如下式(B21-9)至式(B21-26)所示之二胺化合物。 (B21-1) (B21-2) (B21-3) (B21-4) (B21-5) (B21-6) (B21-7) (B21-8) (B21-9) (B21-10) (B21-11) (B21-12) (B21-13) (B21-14) (B21-15) (B21-16) (B21-17) (B21-18) (B21-19) (B21-20) (B21-21) (B21-22) (B21-23) (B21-24) (B21-25) (B21-26) Specific examples of the diamine compound (b2-1) having the above-mentioned specific nitrogen atom-containing structure include: 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, 1,4-bis-(4-aminophenyl)-piperidin , 3,6-diaminoacridine, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, diamine compounds represented by the following formulas (B21-1) to (B21-8), or diamine compounds represented by the following formulas (B21-9) to (B21-26). (B21-1) (B21-2) (B21-3) (B21-4) (B21-5) (B21-6) (B21-7) (B21-8) (B21-9) (B21-10) (B21-11) (B21-12) (B21-13) (B21-14) (B21-15) (B21-16) (B21-17) (B21-18) (B21-19) (B21-20) (B21-21) (B21-22) (B21-23) (B21-24) (B21-25) (B21-26)
所述之二胺化合物(b2-1)可單獨一種使用或混合複數種使用。The diamine compound (b2-1) may be used alone or in combination of two or more.
基於二胺組份(b2)之總使用量為100莫耳,二胺化合物(b2-1)的使用量可為15莫耳至100莫耳,較佳為20莫耳至90莫耳,且更佳為25莫耳至80莫耳。Based on the total usage amount of the diamine component (b2) being 100 mol, the usage amount of the diamine compound (b2-1) may be 15 mol to 100 mol, preferably 20 mol to 90 mol, and more preferably 25 mol to 80 mol.
聚合物的製作方法Polymer production method
聚合物(A)或聚合物(B)之製造可藉由使前述之二胺組份和四羧酸衍生物組份於溶劑中進行(縮聚合)反應來進行。當聚合物(A)或聚合物(B)之一部分具有醯胺酸結構時,例如藉由使四羧酸衍生物組份與二胺組份反應,以獲得具有醯胺酸結構之聚合物(即聚醯胺酸)。前述之溶劑沒有特別之限制,其僅須可溶解所形成之聚合物即可。舉例而言,溶劑之具體例可包含但不限於N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲基亞碸或1,3-二甲基-2-咪唑啶酮。在一些具體例中,當聚合物之溶劑溶解性較高時,溶劑可包含甲乙酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮,或如下式(D-1)至式(D-3)所示之溶劑。於式(D-1)中,Z 1代表碳數為1至3之烷基。於式(D-2)中,Z 2代表碳數為1至3之烷基。於式(D-3)中,Z 3代表示碳數為1至4之烷基。 (D-1) (D-2) (D-3) The production of polymer (A) or polymer (B) can be carried out by reacting the aforementioned diamine component and tetracarboxylic acid derivative component in a solvent (polycondensation). When a portion of polymer (A) or polymer (B) has an acylamidinic acid structure, for example, by reacting the tetracarboxylic acid derivative component with the diamine component, a polymer having an acylamidinic acid structure (i.e., polyacylamidinic acid) can be obtained. The aforementioned solvent is not particularly limited, and it only needs to be able to dissolve the formed polymer. For example, specific examples of the solvent may include but are not limited to N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ-butyrolactone, N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide or 1,3-dimethyl-2-imidazolidinone. In some specific examples, when the solvent solubility of the polymer is high, the solvent may include methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone, or a solvent as shown in the following formula (D-1) to formula (D-3). In formula (D-1), Z 1 represents an alkyl group with a carbon number of 1 to 3. In formula (D-2), Z 2 represents an alkyl group with a carbon number of 1 to 3. In formula (D-3), Z 3 represents an alkyl group with a carbon number of 1 to 4. (D-1) (D-2) (D-3)
前述之溶劑可單獨一種使用,或混合複數種使用。其次,縱使是無法溶解聚合物之溶劑,其仍可在所生成之聚合物不會析出的範圍內,與上述之溶劑混合使用。當二胺組份與四羧酸衍生物組份在溶劑中反應時,反應能以任意之濃度來進行,但較佳為1 wt%至50 wt%,且更佳為5 wt%至30 wt%。反應初始亦可於高濃度進行,之後再額外添加溶劑。進行反應時,二胺組份之總莫耳數與四羧酸衍生物組份之總莫耳數的比值較佳為0.8至1.2。相同於一般之縮聚反應,此莫耳比值越接近1.0時,所形成之聚合物(A)或聚合物(B)的分子量越大。The aforementioned solvents can be used alone or in combination. Secondly, even if the solvent cannot dissolve the polymer, it can still be mixed with the aforementioned solvents within the range that the generated polymer will not precipitate. When the diamine component and the tetracarboxylic acid derivative component react in the solvent, the reaction can be carried out at any concentration, but preferably 1 wt% to 50 wt%, and more preferably 5 wt% to 30 wt%. The reaction can also be carried out at a high concentration initially, and then additional solvent is added. During the reaction, the ratio of the total molar number of the diamine component to the total molar number of the tetracarboxylic acid derivative component is preferably 0.8 to 1.2. Similar to the general polycondensation reaction, the closer this molar ratio is to 1.0, the greater the molecular weight of the polymer (A) or polymer (B) formed.
具有醯胺酸酯結構之聚合物可例如藉由下述等之習知方法來獲得:(1)使上述方法所獲得之聚醯胺酸進一步與酯化劑反應的方法、(2)使四羧酸二酯化合物與二胺化合物進行反應的方法,或(3)使四羧酸二酯二鹵化物與二胺化合物進行反應的方法。A polymer having an acylamidate structure can be obtained, for example, by the following known methods: (1) a method of further reacting the polyacylamidate obtained by the above method with an esterifying agent, (2) a method of reacting a tetracarboxylic acid diester compound with a diamine compound, or (3) a method of reacting a tetracarboxylic acid diester dihalide with a diamine compound.
本發明之液晶配向劑所含的聚合物(A)或聚合物(B)中之醯亞胺化物可例如係藉由將前述所獲得之聚合物予以閉環來獲得。於該醯亞胺化物中,醯胺酸基或其衍生物所具有之官能基的閉環率(亦稱之為醯亞胺化率)不一定須為100%,其醯亞胺化率可根據用途及/或目的任意調整。The imide compound in the polymer (A) or polymer (B) contained in the liquid crystal alignment agent of the present invention can be obtained, for example, by ring-closing the polymer obtained above. In the imide compound, the ring-closing rate (also called the imidization rate) of the functional group possessed by the amide group or its derivative is not necessarily 100%, and the imidization rate can be arbitrarily adjusted according to the use and/or purpose.
對於獲得醯亞胺化物之方法,可例如為將上述反應所獲得之聚合物溶液直接加熱的熱醯亞胺化,或者於聚合物溶液添加觸媒的觸媒醯亞胺化。於溶液中進行熱醯亞胺化時,溫度較佳為100℃至400℃,且更佳為120℃至250℃。於進行熱醯亞胺化時,較佳係一併將醯亞胺化反應所生成之水排除到系統外。The method for obtaining the imidization product may be, for example, thermal imidization in which the polymer solution obtained by the above reaction is directly heated, or catalytic imidization in which a catalyst is added to the polymer solution. When thermal imidization is performed in the solution, the temperature is preferably 100° C. to 400° C., and more preferably 120° C. to 250° C. When thermal imidization is performed, it is preferred to discharge the water generated by the imidization reaction out of the system.
前述之觸媒醯亞胺化可例如為於反應所獲得之聚合物溶液中添加鹼性觸媒及酸酐來進行,較佳係於-20℃至250℃,且更佳為於0℃至180℃進行攪拌。鹼性觸媒之添加量較佳為醯胺酸基之0.5莫耳倍至30莫耳倍,且更佳為2莫耳倍至20莫耳倍;酸酐之添加量較佳為醯胺酸基之1莫耳倍至50莫耳倍,且更佳為3莫耳倍至30莫耳倍。鹼性觸媒之具體例可包含但不限於吡啶、三乙胺、三甲胺、三丁胺或三辛胺等。其中,由於吡啶具有使反應進行之適度鹼性,故較理想。酸酐之具體例可包含但不限於乙酸酐、偏苯三甲酸酐或苯均四酸酐等。其中,若使用乙酸酐,反應結束後之純化較容易,故較理想。觸媒醯亞胺化之醯亞胺化率可藉由調整觸媒量、反應溫度及/或反應時間來控制。The aforementioned catalytic imidization can be carried out, for example, by adding an alkaline catalyst and an acid anhydride to the polymer solution obtained by the reaction, preferably at -20°C to 250°C, and more preferably at 0°C to 180°C with stirring. The amount of the alkaline catalyst added is preferably 0.5 to 30 moles of the amide group, and more preferably 2 to 20 moles; the amount of the acid anhydride added is preferably 1 to 50 moles of the amide group, and more preferably 3 to 30 moles. Specific examples of alkaline catalysts may include but are not limited to pyridine, triethylamine, trimethylamine, tributylamine or trioctylamine. Among them, pyridine is ideal because it has a moderate alkalinity that allows the reaction to proceed. Specific examples of acid anhydrides include but are not limited to acetic anhydride, trimellitic anhydride or pyromellitic anhydride. Among them, if acetic anhydride is used, purification after the reaction is easier, so it is more ideal. The imidization rate of the catalytic imidization can be controlled by adjusting the amount of catalyst, reaction temperature and/or reaction time.
當從上述醯亞胺化之反應溶液回收所形成之醯亞胺化物時,將反應溶液投入到溶劑並使其沉澱即可。沉澱使用之溶劑可例如包含但不限於甲醇、乙醇、異丙醇、丙酮、己烷、丁基賽珞蘇(butyl cellosolve)、庚烷、甲乙酮、甲基異丁基酮、甲苯、苯或水等。過濾並回收投入至溶劑所沉澱之聚合物後,其可於常壓或減壓下,常溫或加熱乾燥。或者,將沉澱回收之聚合物再次溶於溶劑,並進行再沉澱回收,此操作重複進行2次至10次,可減少聚合物中之雜質。所使用之溶劑可例如為醇類或酮類烴等。若使用於其中所選出之三種以上的溶劑,精製之效率可進一步提高,故較理想。When the imide formed is recovered from the above-mentioned imidization reaction solution, the reaction solution is put into a solvent and precipitated. The solvent used for precipitation may include, but is not limited to, methanol, ethanol, isopropanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, toluene, benzene or water. After filtering and recovering the polymer precipitated in the solvent, it can be dried at normal pressure or reduced pressure, at room temperature or by heating. Alternatively, the polymer recovered by precipitation is dissolved in a solvent again and reprecipitated and recovered. This operation is repeated 2 to 10 times to reduce impurities in the polymer. The solvent used may be, for example, an alcohol or a ketone. If more than three selected solvents are used, the refining efficiency can be further improved, which is more ideal.
聚合物之溶液黏度與分子量Solution viscosity and molecular weight of polymers
於配置成濃度為10 wt%至15 wt%之溶液時,本發明之聚合物(A)或聚合物(B)的溶液濃度沒有特別之限制,基於較易操作之觀點,其溶液濃度可例如為10 mPa・s至1000 mPa・s。所述聚合物之溶液黏度(mPa・s)係使用該聚合物之良溶劑(例如:γ-丁內酯或N-甲基-2-吡咯烷酮等)配製成濃度為10 wt%至15 wt%之聚合物溶液,並使用E型旋轉黏度計於25℃所測得之數值。When the solution is prepared into a concentration of 10 wt% to 15 wt%, the solution concentration of the polymer (A) or polymer (B) of the present invention is not particularly limited. Based on the viewpoint of easier operation, the solution concentration can be, for example, 10 mPa·s to 1000 mPa·s. The solution viscosity (mPa·s) of the polymer is a value measured at 25°C using a good solvent for the polymer (e.g., γ-butyrolactone or N-methyl-2-pyrrolidone, etc.) to prepare a polymer solution with a concentration of 10 wt% to 15 wt%.
本發明之聚合物(A)或聚合物(B)利用凝膠滲透層析(GPC)所測得以聚苯乙烯換算之重量平均分子量(M w)較佳為1,000至500,000,且更佳為2,000至500,000。其次,M w與利用GPC所測得以聚苯乙烯換算之數量平均分子量(M n)的比值所表示之分子量分布(M w/M n)較佳為15以下,且更佳為10以下。當聚合物之分子量為前述之分子量範圍時,其可確保液晶顯示元件之良好配向性及安定性。 The weight average molecular weight ( Mw ) of the polymer (A) or polymer (B) of the present invention measured by gel permeation chromatography (GPC) in terms of polystyrene is preferably 1,000 to 500,000, and more preferably 2,000 to 500,000. In addition, the molecular weight distribution ( Mw / Mn ) represented by the ratio of Mw to the number average molecular weight ( Mn ) in terms of polystyrene measured by GPC is preferably 15 or less, and more preferably 10 or less. When the molecular weight of the polymer is within the above molecular weight range, it can ensure good alignment and stability of the liquid crystal display element.
封端劑Capping agent
當合成本發明之聚合物(A)或聚合物(B)時,可使用如前所述之四羧酸衍生物組份及二胺組份,且併用適當的封端劑來合成末端密封型的聚合物。末端密封型的聚合物具有可提升利用塗膜所獲得之液晶配向膜的膜硬度,以及提升密封劑及液晶配向膜之密合特性的效果。本發明之聚合物(A)或聚合物(B)之末端可例如包含胺基、羧基、酸酐基或該等之衍生物。胺基、羧基、酸酐基或該等之衍生物可藉由一般之縮合反應來獲得,或者藉由使用後述之封端劑來密封末端所獲得。相同地,前述之衍生物可例如使用下述之封端劑來獲得。When synthesizing the polymer (A) or polymer (B) of the present invention, the tetracarboxylic acid derivative component and the diamine component as described above can be used, and a suitable end-capping agent can be used to synthesize an end-sealed polymer. The end-sealed polymer has the effect of improving the film hardness of the liquid crystal alignment film obtained by coating, and improving the sealing properties of the sealant and the liquid crystal alignment film. The end of the polymer (A) or polymer (B) of the present invention may, for example, contain an amino group, a carboxyl group, an anhydride group or a derivative thereof. The amino group, the carboxyl group, the anhydride group or a derivative thereof can be obtained by a general condensation reaction, or by using the end-capping agent described later to seal the end. Similarly, the aforementioned derivatives can be obtained, for example, using the following end-capping agent.
舉例而言,封端劑可例如包含但不限於乙酸酐、馬來酸酐、奈地酸酐、鄰苯二甲酸酐、衣康酸酐、環己烷二羧酸酐、3-羥基鄰苯二甲酸酐、偏苯三甲酸酐、3-((3-三甲氧基矽基)丙基)-3,4-二氫呋喃-2,5-二酮、4,5,6,7-四氟異苯并呋喃-1,3-二酮或4-乙炔基鄰苯二甲酸酐等酸酐;二碳酸二第三丁酯或二碳酸二烯丙酯等二碳酸二酯化合物;丙烯醯氯、甲基丙烯醯氯或菸鹼醯氯等氯羰基化合物;苯胺、2-胺基苯酚、3-胺基苯酚、4-胺基水楊酸、5-胺基水楊酸、6-胺基水楊酸、2-胺基苯甲酸、3-胺基苯甲酸、4-胺基苯甲酸、環己胺、正丁胺、正戊胺、正己胺、正庚胺或正辛胺等單元胺化合物;乙基異氰酸酯、苯基異氰酸酯或萘基異氰酸酯等單異氰酸酯化合物等。For example, the end-capping agent may include, but is not limited to, acetic anhydride, maleic anhydride, neddic anhydride, phthalic anhydride, itaconic anhydride, cyclohexanedicarboxylic anhydride, 3-hydroxyphthalic anhydride, trimellitic anhydride, 3-((3-trimethoxysilyl)propyl)-3,4-dihydrofuran-2,5-dione, 4,5,6,7-tetrafluoroisobenzofuran-1,3-dione or 4-ethynylphthalic anhydride; dibutyl dicarbonate or diallyl dicarbonate; Carbonic acid diester compounds; chlorocarbonyl compounds such as acrylyl chloride, methacrylic chloride or nicotinyl chloride; monoamine compounds such as aniline, 2-aminophenol, 3-aminophenol, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine or n-octylamine; monoisocyanate compounds such as ethyl isocyanate, phenyl isocyanate or naphthyl isocyanate, etc.
所述封端劑可單獨一種使用或混合複數種使用。The blocking agents may be used alone or in combination of two or more.
基於二胺組份的總使用量為100莫耳份,封端劑之使用量較佳可為0.01莫耳份至20莫耳份,且更佳為0.01莫耳份至10莫耳份。Based on 100 mol parts of the total usage of the diamine component, the usage of the end-capping agent is preferably 0.01 mol parts to 20 mol parts, and more preferably 0.01 mol parts to 10 mol parts.
液晶配向劑中之其他成分Other ingredients in liquid crystal alignment agents
本發明之液晶配向劑可包含聚合物(A)、視需要所添加之聚合物(B)。除聚合物(A)與聚合物(B),本發明之液晶配向劑可選擇性地包含其他聚合物。其他聚合物之種類可例如包含但不限於聚酯、聚醯胺、聚脲、聚有機矽氧烷、纖維素衍生物、聚縮醛、聚苯乙烯或其衍生物、聚(苯乙烯-苯基馬來醯亞胺)衍生物,或聚(甲基)丙烯酸酯等。The liquid crystal alignment agent of the present invention may include polymer (A) and polymer (B) added as needed. In addition to polymer (A) and polymer (B), the liquid crystal alignment agent of the present invention may selectively include other polymers. The types of other polymers may include, but are not limited to, polyester, polyamide, polyurea, polyorganosiloxane, cellulose derivatives, polyacetal, polystyrene or its derivatives, poly(styrene-phenylmaleimide) derivatives, or poly(meth)acrylate, etc.
溶劑(C)Solvent (C)
基於形成均勻薄膜的觀點,液晶配向劑採取塗佈液之形態,以製作液晶配向膜。本發明之液晶配向劑較佳為含有上述聚合物成分及有機溶劑(後述將其稱之為溶劑(C))之塗佈液。其中,基於所設定之欲形成的塗膜厚度,液晶配向劑中之聚合物濃度可適當改變。基於形成均勻且無缺陷之塗膜的觀點,液晶配向劑中之聚合物濃度較佳為1 wt%以上。基於溶液之保存安定性的觀點,液晶配向劑中之聚合物濃度較佳為10 wt%以下。理想的聚合物濃度可為2 wt%至8 wt%。液晶配向劑中之聚合物(A)的含量可藉由液晶配向劑之塗佈方法及/或所欲液晶配向膜之膜厚來適當改變,其較佳可為2 wt%至10 wt%,且更佳為3 wt%至7 wt%。From the perspective of forming a uniform film, the liquid crystal alignment agent is in the form of a coating liquid to produce a liquid crystal alignment film. The liquid crystal alignment agent of the present invention is preferably a coating liquid containing the above-mentioned polymer component and an organic solvent (hereinafter referred to as solvent (C)). Among them, based on the set coating thickness to be formed, the polymer concentration in the liquid crystal alignment agent can be appropriately changed. From the perspective of forming a uniform and defect-free coating, the polymer concentration in the liquid crystal alignment agent is preferably above 1 wt%. From the perspective of the storage stability of the solution, the polymer concentration in the liquid crystal alignment agent is preferably below 10 wt%. The ideal polymer concentration can be 2 wt% to 8 wt%. The content of the polymer (A) in the liquid crystal alignment agent can be appropriately changed by the coating method of the liquid crystal alignment agent and/or the film thickness of the desired liquid crystal alignment film, and is preferably 2 wt % to 10 wt %, and more preferably 3 wt % to 7 wt %.
液晶配向劑所含之有機溶劑沒有特別之限制,其僅須可將前述之聚合物均勻溶解即可。其具體例可例如包含但不限於N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N,N-二甲基乳醯胺、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、二甲基亞碸、γ-丁內酯、γ-戊內酯、1,3-二甲基-2-咪唑啶酮、甲乙酮、環己酮、環戊酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺、N-(正丙基)-2-吡咯烷酮、N-異丙基-2-吡咯烷酮、N-(正丁基)-2-吡咯烷酮、N-(第三丁基)-2-吡咯烷酮、N-(正戊基)-2-吡咯烷酮、N-甲氧基丙基-2-吡咯烷酮、N-乙氧基乙基-2-吡咯烷酮、N-甲氧基丁基-2-吡咯烷酮或N-環己基-2-吡咯烷酮等,而前述之有機溶劑亦稱之為良溶劑。其中,N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺或γ-丁內酯為較佳。基於液晶配向劑中溶劑的總使用量為100 wt%,良溶劑之使用量可為20 wt%至99 wt%,較佳為20 wt%至90 wt%,且更佳為30 wt%至80 wt%。There is no particular limitation on the organic solvent contained in the liquid crystal alignment agent, and it only needs to be able to uniformly dissolve the aforementioned polymer. Specific examples thereof include, but are not limited to, N,N-dimethylformamide, N,N-dimethylacetamide, N,N-dimethyllactamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethylsulfoxide, γ-butyrolactone, γ-valerolactone, 1,3-dimethyl-2-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide, N-(n-propyl)-2-pyrrolidone, N-isopropyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(tert-butyl)-2-pyrrolidone, N-(n-pentyl)-2-pyrrolidone, N-methoxypropyl-2-pyrrolidone, N-ethoxyethyl-2-pyrrolidone, N-methoxybutyl-2-pyrrolidone or N-cyclohexyl-2-pyrrolidone, etc., and the aforementioned organic solvents are also called good solvents. Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide or γ-butyrolactone is preferred. Based on the total usage of the solvent in the liquid crystal alignment agent being 100 wt %, the usage of the good solvent may be 20 wt % to 99 wt %, preferably 20 wt % to 90 wt %, and more preferably 30 wt % to 80 wt %.
其次,液晶配向劑中之有機溶劑較佳係併用前述之溶劑,以及可提升液晶配向劑塗佈時之塗佈性與塗膜之表面平滑性的溶劑(亦稱之為貧溶劑)的混合溶劑。所併用之不良溶劑之具體可例如但不限於後述之溶劑。基於液晶配向劑中之溶劑的總使用量為100 wt%,貧溶劑之使用量較佳為1 wt%至80 wt%,更佳為10 wt%至80 wt%,且尤佳為20 wt%至70 wt%。貧溶劑之種類及使用量可依據液晶配向劑之塗佈裝置、塗佈條件及/或塗佈環境等適當選擇。Secondly, the organic solvent in the liquid crystal alignment agent is preferably a mixed solvent of the aforementioned solvent and a solvent (also called a poor solvent) that can improve the coating property of the liquid crystal alignment agent and the surface smoothness of the coating film. The specific poor solvent used in combination can be, for example, but not limited to the solvent described below. Based on the total usage of the solvent in the liquid crystal alignment agent being 100 wt%, the usage of the poor solvent is preferably 1 wt% to 80 wt%, more preferably 10 wt% to 80 wt%, and particularly preferably 20 wt% to 70 wt%. The type and amount of the poor solvent can be appropriately selected according to the coating device, coating conditions and/or coating environment of the liquid crystal alignment agent.
舉例而言,貧溶劑可例如為:二異丙醚、二異丁醚、二異丁基甲醇(2,6-二甲基-4-庚醇)、乙二醇二甲醚、乙二醇二乙醚、乙二醇二丁醚、1,2-丁氧基乙烷、二乙二醇二甲醚、二乙二醇二乙醚、4-羥基-4-甲基-2-戊酮、二乙二醇甲基乙醚、二乙二醇二丁醚、3-乙氧基丁基乙酸酯、1-甲基戊基乙酸酯、2-乙基丁基乙酸酯、2-乙基己基乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、碳酸伸丙酯、碳酸伸乙酯、乙二醇單丁醚(丁基賽珞蘇)、乙二醇單異戊醚、乙二醇單己醚、丙二醇單丁醚、1-(2-丁氧基乙氧基)-2-丙醇、2-(2-丁氧基乙氧基)-1-丙醇、丙二醇單甲醚乙酸酯、丙二醇二乙酸酯、二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇二甲醚、乙二醇單丁醚乙酸酯、二乙二醇單乙醚乙酸酯、二乙二醇單丁醚乙酸酯、2-(2-乙氧基乙氧基)乙基乙酸酯、二乙二醇乙酸酯、丙二醇二乙酸酯、乙酸正丁酯、乙酸丙二醇單乙醚、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、3-甲氧基丙酸乙酯、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸正丁酯、乳酸異戊酯、二乙二醇單乙醚,或二異丁基酮(2,6-二甲基-4-庚酮)等。For example, the poor solvent may be, for example, diisopropyl ether, diisobutyl ether, diisobutyl carbinol (2,6-dimethyl-4-heptanol), ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, 1,2-butoxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, 4-hydroxy-4-methyl-2-pentanone, diethylene glycol methyl ethyl ether, diethylene glycol dibutyl ether, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl acetate, ethylene glycol monoacetate, ethylene glycol diacetate, propylene carbonate, ethyl carbonate, ethylene glycol monobutyl ether (butyl celoxylate), ethylene glycol monoisopentyl ether, ethylene glycol monohexyl ether, propylene glycol monobutyl ether, 1-(2-butoxyethoxy) )-2-propanol, 2-(2-butoxyethoxy)-1-propanol, propylene glycol monomethyl ether acetate, propylene glycol diacetate, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol dimethyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, 2-(2-ethoxyethoxy)ethyl acetate, diethylene glycol acetate, propylene glycol diacetate, n-butyl acetate, propylene glycol monoethyl ether acetate, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, propyl 3-methoxypropionate, butyl 3-methoxypropionate, n-butyl lactate, isoamyl lactate, diethylene glycol monoethyl ether, or diisobutyl ketone (2,6-dimethyl-4-heptanone), etc.
其中,二異丁基甲醇、丙二醇單丁醚、丙二醇二乙酸酯、二乙二醇二乙醚、二丙二醇單甲醚、二丙二醇二甲醚、4-羥基-4-甲基-2-戊酮、乙二醇單丁醚、乙二醇單丁醚乙酸酯,或二異丁基酮為較佳。Among them, diisobutyl carbinol, propylene glycol monobutyl ether, propylene glycol diacetate, diethylene glycol diethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, or diisobutyl ketone is preferred.
良溶劑與貧溶劑之溶劑組合較佳可例如但不限於N-甲基-2-吡咯烷酮與乙二醇單丁醚;N-甲基-2-吡咯烷酮、γ-丁內酯與乙二醇單丁醚;N-甲基-2-吡咯烷酮、γ-丁內酯與丙二醇單丁醚;N-乙基-2-吡咯烷酮與丙二醇單丁醚;N-乙基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮;N-乙基-2-吡咯烷酮與丙二醇二乙酸酯;N,N-二甲基乳醯胺與二異丁基酮;N-甲基-2-吡咯烷酮與3-乙氧基丙酸乙酯;N-乙基-2-吡咯烷酮與3-乙氧基丙酸乙酯;N-甲基-2-吡咯烷酮與乙二醇單丁醚乙酸酯;N-乙基-2-吡咯烷酮與二丙二醇二甲醚;N,N-二甲基乳醯胺與乙二醇單丁醚;N,N-二甲基乳醯胺與丙二醇二乙酸酯;N-乙基-2-吡咯烷酮與二乙二醇二乙醚;N,N-二甲基乳醯胺與二乙二醇二乙醚;N-甲基-2-吡咯烷酮、γ-丁內酯、4-羥基-4-甲基-2-戊酮與二乙二醇二乙醚;N-乙基-2-吡咯烷酮、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮;N-乙基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與丙二醇單丁醚;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與二異丁基酮;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與二丙二醇單甲醚;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與丙二醇單丁醚;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯;γ-丁內酯、4-羥基-4-甲基-2-戊酮與二異丁基酮;γ-丁內酯、4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯;N-甲基-2-吡咯烷酮、γ-丁內酯、丙二醇單丁醚與二異丁基酮;N-甲基-2-吡咯烷酮、γ-丁內酯與丙二醇單丁醚與二異丙醚;N-甲基-2-吡咯烷酮、γ-丁內酯、丙二醇單丁醚與二異丁基甲醇;N-甲基-2-吡咯烷酮、γ-丁內酯與二丙二醇二甲醚;N-甲基-2-吡咯烷酮、丙二醇單丁醚與二丙二醇二甲醚;N-乙基-2-吡咯烷酮、丙二醇單丁醚與二丙二醇單甲醚;N-乙基-2-吡咯烷酮、丙二醇單丁醚與丙二醇二乙酸酯;N-乙基-2-吡咯烷酮、丙二醇單丁醚與二異丁基酮;N-乙基-2-吡咯烷酮、γ-丁內酯與二異丁基酮;或者N-乙基-2-吡咯烷酮、N,N-二甲基乳醯胺與二異丁基酮等。The preferred solvent combination of good solvent and poor solvent can be, for example, but not limited to, N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone and ethylene glycol monobutyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone and propylene glycol monobutyl ether; N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether; N-ethyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone; N-ethyl-2-pyrrolidone and propylene glycol diacetate; N,N-dimethyl lactamide and diisobutyl ketone; N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate; N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate; N-methyl-2-pyrrolidone and ethyl Glycol monobutyl ether acetate; N-ethyl-2-pyrrolidone and dipropylene glycol dimethyl ether; N,N-dimethyl lactamide and ethylene glycol monobutyl ether; N,N-dimethyl lactamide and propylene glycol diacetate; N-ethyl-2-pyrrolidone and diethylene glycol diethyl ether; N,N-dimethyl lactamide and diethylene glycol diethyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone and diethylene glycol diethyl ether; N-ethyl-2-pyrrolidone, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone; N-ethyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether; N-methyl-2-pyrrolidone, 4-Hydroxy-4-methyl-2-pentanone and diisobutyl ketone; N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and dipropylene glycol monomethyl ether; N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether; N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate; γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone and diisobutyl ketone; γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate; N-methyl-2-pyrrolidone, γ-butyrolactone, propylene glycol monobutyl ether and diisobutyl ketone; N-methyl-2-pyrrolidone, γ-butyrolactone and propylene glycol diacetate Glycol monobutyl ether and diisopropyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone, propylene glycol monobutyl ether and diisobutyl carbinol; N-methyl-2-pyrrolidone, γ-butyrolactone and dipropylene glycol dimethyl ether; N-methyl-2-pyrrolidone, propylene glycol monobutyl ether and dipropylene glycol dimethyl ether; N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and dipropylene glycol monomethyl ether; N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and propylene glycol diacetate; N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and diisobutyl ketone; N-ethyl-2-pyrrolidone, γ-butyrolactone and diisobutyl ketone; or N-ethyl-2-pyrrolidone, N,N-dimethyllactamide and diisobutyl ketone, etc.
前述之溶劑(C)可單獨一種使用或混合複數種使用。The aforementioned solvent (C) may be used alone or in combination of two or more.
基於聚合物(A)與聚合物(B)合計的使用量為100重量份,溶劑(C)的使用量可為800重量份至4000重量份,較佳為900重量份至3500重量份,且更佳為1000至3000重量份。Based on 100 parts by weight of the total amount of the polymer (A) and the polymer (B), the amount of the solvent (C) may be 800 to 4000 parts by weight, preferably 900 to 3500 parts by weight, and more preferably 1000 to 3000 parts by weight.
添加劑Additives
本發明之液晶配向劑亦可選擇性添加聚合物成分及有機溶劑以外的成分(下述稱之為添加劑成分)。此些添加劑成分可例如包含但不限於:用以提高液晶配向膜與基板之密合性或液晶配向膜與密封劑之密合性的密合助劑、用以提高液晶配向膜之強度的化合物(下述稱之為交聯性化合物)、用以促進醯亞胺化的化合物、用以調整液晶配向膜之介電常數或電阻之介電體或導電物質等。The liquid crystal alignment agent of the present invention may also selectively add components other than polymer components and organic solvents (hereinafter referred to as additive components). These additive components may include, for example, but are not limited to: adhesion aids for improving the adhesion between the liquid crystal alignment film and the substrate or the adhesion between the liquid crystal alignment film and the sealant, compounds for improving the strength of the liquid crystal alignment film (hereinafter referred to as cross-linking compounds), compounds for promoting imidization, dielectrics or conductive substances for adjusting the dielectric constant or resistance of the liquid crystal alignment film, etc.
密合助劑Sealing agent
前述之密合助劑可例如為3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-胺基丙基二乙氧基甲基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽基丙基三伸乙基三胺、N-三甲氧基矽基丙基三伸乙基三胺、乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、3-環氧丙氧基丙基三乙氧基矽烷、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷、3-甲基丙烯醯氧基丙基三乙氧基矽烷、3-丙烯醯氧基丙基三甲氧基矽烷、參(3-三甲氧基矽基丙基)異氰尿酸酯,或3-異氰酸酯丙基三乙氧基矽烷等矽烷偶合劑。使用密合助劑時,基於對於AC殘影展現良好耐性之觀點,相對於液晶配向劑中聚合物的總使用量為100重量份,密合助劑之使用量較佳為0.1重量份至30重量份,且更佳為0.1重量份至20重量份。The aforementioned adhesion aid may be, for example, 3-aminopropyl trimethoxysilane, 3-aminopropyl triethoxysilane, 3-aminopropyl diethoxymethyl silane, 2-aminopropyl trimethoxysilane, 2-aminopropyl triethoxysilane, N-(2-aminoethyl)-3-aminopropyl trimethoxysilane, N-(2-aminoethyl)-3-aminopropyl methyl dimethoxysilane, 3-ureidopropyl trimethoxysilane, 3-ureidopropyl triethoxysilane, N-ethoxycarbonyl-3-aminopropyl trimethoxysilane, N-ethoxycarbonyl-3-aminopropyl triethoxysilane, N-triethoxysilylpropyl triethyl triamine, N-trimethoxysilylpropyl triethyl triamine, vinyl trimethoxysilane, Silane, vinyl triethoxysilane, 2-(3,4-epoxyhexyl)ethyl trimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane, 3-methacryloyloxypropylmethyldimethoxysilane Silane coupling agents such as methoxysilane, 3-methacryloxypropyl trimethoxysilane, 3-methacryloxypropyl methyldiethoxysilane, 3-methacryloxypropyl triethoxysilane, 3-acryloxypropyl trimethoxysilane, tris(3-trimethoxysilylpropyl) isocyanurate, or 3-isocyanatepropyl triethoxysilane. When a bonding agent is used, based on the viewpoint of exhibiting good resistance to AC afterimage, the amount of the bonding agent used is preferably 0.1 to 30 parts by weight, and more preferably 0.1 to 20 parts by weight, relative to 100 parts by weight of the total amount of the polymer used in the liquid crystal alignment agent.
交聯性化合物Cross-linked compounds
對於前述之交聯性化合物,基於對AC殘影展現良好耐性且有效改善膜強度的觀點,其可為具有環氧乙烷基、環氧丙烷基、選自於由如下式(E1)所示之基團及下式(E2)所示之基團所組成之群組中的至少一種基團之化合物,或選自如下式(E3)所示之化合物中的化合物。 (E1) (E2) (E3) The crosslinking compound mentioned above may be a compound having an ethylene oxide group, a propylene oxide group, at least one group selected from the group consisting of a group represented by the following formula (E1) and a group represented by the following formula (E2), or a compound selected from the compound represented by the following formula (E3), from the viewpoint of exhibiting good resistance to AC afterimage and effectively improving film strength. (E1) (E2) (E3)
於式(E1)中,G 1及G 2各自獨立地表示氫原子、碳數為1至3之烷基或-CH 2-OH。於式(E2)中,G 3表示碳數為1至6之烷基、碳數為2至6之烯基或碳數為2至6之炔基。G 4表示氫原子、碳數為1至4之烷基、碳數為2至6之烯基或碳數為2至6之炔基。於式(E3)中,G 5表示含有芳香環之(g1+g2)價有機基團。G 6表示氫原子或碳數為1至5之烷基。g1表示1至6之整數,g2表示0至4之整數。 In formula (E1), G1 and G2 each independently represent a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, or -CH2 - OH. In formula (E2), G3 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or an alkynyl group having 2 to 6 carbon atoms. G4 represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or an alkynyl group having 2 to 6 carbon atoms. In formula (E3), G5 represents a (g1+g2)-valent organic group containing an aromatic ring. G6 represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms. g1 represents an integer from 1 to 6, and g2 represents an integer from 0 to 4.
於式(E3)中,G 5所代表之具有芳香環的(g1+g2)價有機基團可列舉碳數為6至30之(g1+g2)價芳香族烴基、碳數為6至30之芳香族烴基直接或介隔連結基所鍵結形成之(g1+g2)價有機基團,或具有芳香族雜環之(g1+g2)價基團。所述芳香族烴可例如為苯或萘等。所述芳香族雜環可列舉為上述特定之含氮原子結構之例示芳香族雜環。所述連結基可列舉碳數為1至10之伸烷基或從該伸烷基取走一個氫原子之基團,或者二價或三價之環己烷等。其中,該伸烷基之任意氫原子也可被取代為氟原子或三氟甲基等有機基團。於式(E3)中,G 6所代表之碳數為1至5之烷基可列舉甲基、乙基、丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基或正戊基。 In formula (E3), the (g1+g2)-valent organic group having an aromatic ring represented by G5 can be exemplified by a (g1+g2)-valent aromatic hydrocarbon group having 6 to 30 carbon atoms, a (g1+g2)-valent organic group formed by directly or via a linking group bonding an aromatic hydrocarbon group having 6 to 30 carbon atoms, or a (g1+g2)-valent group having an aromatic heterocyclic ring. The aromatic hydrocarbon can be, for example, benzene or naphthalene. The aromatic heterocyclic ring can be exemplified by the aromatic heterocyclic rings of the above-mentioned specific nitrogen atom-containing structure. The linking group can be exemplified by an alkylene group having 1 to 10 carbon atoms or a group obtained by removing a hydrogen atom from the alkylene group, or a divalent or trivalent cyclohexane. Wherein, any hydrogen atom of the alkylene group may be substituted by a fluorine atom or an organic group such as trifluoromethyl. In formula (E3), the alkyl group with 1 to 5 carbon atoms represented by G6 may be methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl or n-pentyl.
具環氧乙烷基之化合物Compounds with ethylene oxide
具環氧乙烷基之化合物的具體例可列舉N,N,N',N'-四環氧丙基間二甲苯二胺、1,3-雙(N,N-二環氧丙胺基甲基)環己烷、N,N,N',N'-四環氧丙基-4,4'-二胺基二苯基甲烷、N,N,N',N'-四環氧丙基-對苯二胺、如下式(E4)至式(E6)所示等含有氮原子之化合物。 (E4) (E5) (E6) Specific examples of the compound having an ethylene oxide group include N,N,N',N'-tetraethylene oxide propyl-m-xylene diamine, 1,3-bis(N,N-diethylene oxide propylaminomethyl)cyclohexane, N,N,N',N'-tetraethylene oxide propyl-4,4'-diaminodiphenylmethane, N,N,N',N'-tetraethylene oxide propyl-p-phenylenediamine, and compounds containing nitrogen atoms such as those represented by the following formulas (E4) to (E6). (E4) (E5) (E6)
具有環氧丙烷基之化合物Compounds with propylene oxide
具有環氧丙烷基之化合物的具體例可列舉如下式(E7)至式(E16)所示之化合物。 (E7) (E8) (E9) (E10) (E11) (E12) (E13) (E14) (E15) (E16) Specific examples of the compound having an propylene oxide group include compounds represented by the following formula (E7) to formula (E16). (E7) (E8) (E9) (E10) (E11) (E12) (E13) (E14) (E15) (E16)
於式(E15)中,R代表 ,其中「*」代表鍵結位置。 In formula (E15), R represents , where "*" represents the key position.
具有如式(E1)所示之基團的化合物Compounds having a group represented by formula (E1)
具有如式(E1)所示之基團的化合物之具體例可列舉如下式(E1-1)至式(E1-12)所示之化合物。 (E1-1) (E1-2) (E1-3) (E1-4) (E1-5) (E1-6) (E1-7) (E1-8) (E1-9) (E1-10) (E1-11) (E1-12) Specific examples of the compound having the group represented by formula (E1) include compounds represented by the following formulas (E1-1) to (E1-12). (E1-1) (E1-2) (E1-3) (E1-4) (E1-5) (E1-6) (E1-7) (E1-8) (E1-9) (E1-10) (E1-11) (E1-12)
具有如式(E2)所示基團之化合物Compounds having a group represented by formula (E2)
具有如式(E2)所示基團之化合物的具體例可列舉如下式(E2-1)至式(E2-4)所示之化合物。 (E2-1) (E2-2) (E2-3) (E2-4) Specific examples of the compound having the group represented by formula (E2) include compounds represented by the following formulas (E2-1) to (E2-4). (E2-1) (E2-2) (E2-3) (E2-4)
具有如式(E3)所示基團之化合物Compounds having a group represented by formula (E3)
具有如式(E3)所示基團之化合物的具體例可如下式(E3-1)至式(E3-10)所示之化合物。 (E3-1) (E3-2) (E3-3) (E3-4) (E3-5) (E3-6) (E3-7) (E3-8) (E3-9) (E3-10) Specific examples of the compound having a group represented by formula (E3) include compounds represented by the following formulas (E3-1) to (E3-10). (E3-1) (E3-2) (E3-3) (E3-4) (E3-5) (E3-6) (E3-7) (E3-8) (E3-9) (E3-10)
本發明之液晶配向劑中,基於液晶配向劑中聚合物之總使用量為100重量份,交聯性化合物之使用量較佳為0.5重量份至20重量份。其中,基於交聯反應之進行與對於AC殘影展現良好耐性之觀點,交聯性化合物之使用量更佳為1重量份至15重量份。In the liquid crystal alignment agent of the present invention, based on the total usage of the polymer in the liquid crystal alignment agent being 100 parts by weight, the usage of the crosslinking compound is preferably 0.5 parts by weight to 20 parts by weight. Among them, based on the viewpoint of the crosslinking reaction and the good resistance to AC afterimage, the usage of the crosslinking compound is more preferably 1 part by weight to 15 parts by weight.
促進醯亞胺化之化合物Compounds that promote imidization
前述用以促進醯亞胺化之化合物較佳為具有鹼性部位(例如:一級胺基、脂肪族雜環(如吡咯啶骨架)、芳香族雜環(如咪唑環或吲哚環),或胍基等)之化合物(惟上述交聯性化合物及密合助劑除外),或者煅燒時會產生所述鹼性部位之化合物。更佳地,促進醯亞胺化之化合物為煅燒時會產生所述鹼性部位之化合物,其具體例可例如為胺基酸所具有之鹼性部位的一部分或全部係被保護之胺基酸。上述胺基酸之具體例可列舉甘胺酸、丙胺酸、半胱胺酸、甲硫胺酸、天冬醯胺、麩醯胺酸、纈胺酸、白胺酸、苯丙胺酸、酪胺酸、色胺酸、脯胺酸、羥基脯胺酸、精胺酸、組胺酸、離胺酸,或鳥胺酸。基於促進醯亞胺化之化合物之目的,更佳的具體例可列舉為N-α-(9-茀基甲氧基羰基)-N-τ-(第三丁氧基羰基)-L-組胺酸。The aforementioned compound for promoting imidization is preferably a compound having a basic site (e.g., a primary amine group, an aliphatic heterocycle (e.g., a pyrrolidine skeleton), an aromatic heterocycle (e.g., an imidazole ring or an indole ring), or a guanidine group, etc.) (excluding the aforementioned cross-linking compound and the bonding aid), or a compound that generates the aforementioned basic site upon calcination. More preferably, the compound for promoting imidization is a compound that generates the aforementioned basic site upon calcination, and a specific example thereof may be an amino acid in which a part or all of the basic site of the amino acid is protected. Specific examples of the above amino acids include glycine, alanine, cysteine, methionine, asparagine, glutamine, valine, leucine, phenylalanine, tyrosine, tryptophan, proline, hydroxyproline, arginine, histidine, lysine, or ornithine. For the purpose of promoting the imidization compound, a more preferred specific example is N-α-(9-fluorenylmethoxycarbonyl)-N-τ-(tert-butyloxycarbonyl)-L-histidine.
液晶配向膜與液晶顯示元件的製作方法Liquid crystal alignment film and method for manufacturing liquid crystal display element
本發明之液晶配向膜係由前述之液晶配向劑所獲得。本發明之液晶配向膜可作為水平配向型或垂直配向型(VA型)之液晶配向膜,且其係適合於IPS方式或FFS方式等水平配向型之液晶顯示元件的液晶配向膜。本發明之液晶顯示元件具備所述之液晶配向膜。本發明之液晶顯示元件可例如藉由下述之步驟(1)至步驟(4)或步驟(1)至步驟(2)與步驟(4)的方法來製作。The liquid crystal alignment film of the present invention is obtained from the aforementioned liquid crystal alignment agent. The liquid crystal alignment film of the present invention can be used as a horizontal alignment type or a vertical alignment type (VA type) liquid crystal alignment film, and is a liquid crystal alignment film suitable for a horizontal alignment type liquid crystal display element such as an IPS method or a FFS method. The liquid crystal display element of the present invention has the aforementioned liquid crystal alignment film. The liquid crystal display element of the present invention can be manufactured, for example, by the following method of steps (1) to (4) or steps (1) to (2) and step (4).
步驟(1):將液晶配向劑塗佈於基板上Step (1): Apply liquid crystal alignment agent on the substrate
利用如輥塗法、旋塗法、印刷法或噴墨法等適當的塗佈方法,在設有經圖案化之透明導電膜的基板之一面上塗佈本發明之液晶配向劑。其中,基板沒有特別之限制,其僅須為高透明性之基板即可,也可將玻璃基板或氮化矽基板與壓克力基板或聚碳酸酯基板等塑膠基板併用。其次,於反射型之液晶顯示元件中,若僅是單側之基板,也能使用矽晶圓等不透明物,且所使用之電極亦可為鋁等可反射光之材料。再者,製作IPS型或FFS型之液晶元件時,梳齒型係使用已設置經圖案化之透明導電膜或金屬膜所構成之電極基板及未設置電極之對向基板。The liquid crystal alignment agent of the present invention is applied on one side of a substrate provided with a patterned transparent conductive film by using a suitable coating method such as roller coating, spin coating, printing or inkjet. There is no particular limitation on the substrate, and it only needs to be a highly transparent substrate. A glass substrate or a silicon nitride substrate can also be used together with a plastic substrate such as an acrylic substrate or a polycarbonate substrate. Secondly, in a reflective liquid crystal display element, if it is only a single-sided substrate, an opaque material such as a silicon wafer can also be used, and the electrode used can also be a light-reflecting material such as aluminum. Furthermore, when manufacturing IPS type or FFS type liquid crystal elements, the comb-tooth type uses an electrode substrate composed of a patterned transparent conductive film or metal film and an opposite substrate without an electrode.
將液晶配向劑塗佈於基板並成膜之方法可列舉網版印刷、平版印刷、柔版印刷、噴墨法或噴塗法等。其中,成膜之方法較佳係利用噴墨法之塗佈。The method of coating the liquid crystal alignment agent on the substrate and forming a film can be listed as screen printing, lithography, flexographic printing, inkjet method or inkjet coating method, etc. Among them, the film forming method is preferably coating by inkjet method.
步驟(2):煅燒所塗佈之液晶配向劑Step (2): calcining the coated liquid crystal alignment agent
步驟(2)係煅燒已塗佈於基板上之液晶配向劑,以形成膜的步驟。將液晶配向劑塗佈於基板上後,可利用熱板、熱循環型烘箱或IR(紅外線)型烘箱等加熱手段使溶劑蒸發,或進行聚醯胺酸或聚醯胺酸酯之熱醯亞胺化。已塗佈本發明之液晶配向劑後所進行之乾燥與煅燒步驟可選擇任意之溫度及時間,且可進行多次乾燥或煅燒步驟。乾燥溫度可例如為40℃至180℃。基於縮短處理之觀點,可於40℃至150℃下進行。乾燥時間沒有特別限定,其可例如為1分鐘至10分鐘或1分鐘至5分鐘。進行聚醯胺酸或聚醯胺酸酯之熱醯亞胺化時,在前述之乾燥步驟後,可進一步於例如150℃至300℃或150℃至250℃之溫度下進行煅燒步驟。煅燒時間沒有特別之限定,其可列舉5分鐘至40分鐘或5分鐘至30分鐘。煅燒後之膜狀物若太薄則液晶顯示元件之可靠性會降低,故膜狀物厚度較佳為5 nm至300 nm,且更佳為10 nm至200 nm。Step (2) is a step of calcining the liquid crystal alignment agent coated on the substrate to form a film. After the liquid crystal alignment agent is coated on the substrate, the solvent can be evaporated by heating means such as a hot plate, a heat circulation oven or an IR (infrared) oven, or thermal imidization of polyamine or polyamine ester can be performed. The drying and calcining steps performed after the liquid crystal alignment agent of the present invention has been coated can be selected at any temperature and time, and multiple drying or calcining steps can be performed. The drying temperature can be, for example, 40°C to 180°C. From the perspective of shortening the process, it can be performed at 40°C to 150°C. There is no particular limitation on the drying time, and it may be, for example, 1 minute to 10 minutes or 1 minute to 5 minutes. When performing thermal imidization of polyamine acid or polyamine ester, after the aforementioned drying step, a calcination step may be further performed at a temperature of, for example, 150°C to 300°C or 150°C to 250°C. There is no particular limitation on the calcination time, and it may be, for example, 5 minutes to 40 minutes or 5 minutes to 30 minutes. If the film after calcination is too thin, the reliability of the liquid crystal display element will be reduced, so the film thickness is preferably 5 nm to 300 nm, and more preferably 10 nm to 200 nm.
步驟(3):對步驟(2)所獲得之膜進行配向處理Step (3): Performing an alignment treatment on the film obtained in step (2)
步驟(3)係視情形對步驟(2)所獲得之膜進行配向處理。換言之,於IPS方式或FFS方式等水平配向型之液晶顯示元件中,對該塗膜實施配向處理,以賦予配向能力。另一方面,於VA方式或PSA模式等垂直配向型之液晶顯示元件中,可將已形成之塗膜直接作為液晶配向膜使用,但也可對該塗膜進行配向處理,以賦予配向能力。液晶配向膜之配向處理可列舉摩擦處理法或光配向處理法,其較佳為光配向處理法。光配向處理法可列舉於上述膜狀物之表面照射已沿一定方向偏向之放射線,並視情形,較佳為以150℃至250℃之溫度加熱,以賦予液晶配向性(亦稱之為液晶配向能力)的方法。放射線可使用波長為100 nm至800 nm之紫外線或可見光線。其中,放射線較佳為波長為100 nm至400 nm之紫外線,且更佳為200 nm至400 nm之紫外線。Step (3) is to perform an alignment treatment on the film obtained in step (2) as appropriate. In other words, in a horizontal alignment type liquid crystal display element such as the IPS mode or the FFS mode, the coating film is subjected to an alignment treatment to give it an alignment capability. On the other hand, in a vertical alignment type liquid crystal display element such as the VA mode or the PSA mode, the formed coating film can be directly used as a liquid crystal alignment film, but the coating film can also be subjected to an alignment treatment to give it an alignment capability. The alignment treatment of the liquid crystal alignment film can be exemplified by a friction treatment method or a photo-alignment treatment method, and the photo-alignment treatment method is preferred. The photo-alignment treatment method can be listed as a method of irradiating the surface of the above-mentioned film-like object with radiation that has been deflected in a certain direction, and preferably heating it at a temperature of 150°C to 250°C to give liquid crystal alignment (also known as liquid crystal alignment ability). The radiation can use ultraviolet light or visible light with a wavelength of 100 nm to 800 nm. Among them, the radiation is preferably ultraviolet light with a wavelength of 100 nm to 400 nm, and more preferably ultraviolet light with a wavelength of 200 nm to 400 nm.
前述放射線之照射量可為1 mJ/cm 2至10,000 mJ/cm 2,較佳為100 mJ/cm 2至5,000 mJ/cm 2,更佳為100 mJ/cm 2至1500 mJ/cm 2,且尤佳為100 mJ/cm 2至1000 mJ/cm 2。使用一般液晶配向劑時,配向處理之光照射量為100 mJ/cm 2至5000 mJ/cm 2,但本發明之液晶配向劑,即使配向處理之光照射量減少,其仍可獲得膜面內之液晶配向性的變異(不均勻性)有效被抑制之液晶配向膜。於照射放射線時,為了改善液晶配向性,前述膜狀物之基板可於照射同時,以50℃至250℃進行加熱。依此方式所製作之液晶配向膜可使液晶分子按一定的方向穩定配向。其次,前述方法中已照射經偏光之放射線的液晶配向膜可使用溶劑進行接觸處理,或者將已照射放射線之液晶配向膜進行加熱處理。 The radiation dose may be 1 mJ/cm 2 to 10,000 mJ/cm 2 , preferably 100 mJ/cm 2 to 5,000 mJ/cm 2 , more preferably 100 mJ/cm 2 to 1500 mJ/cm 2 , and particularly preferably 100 mJ/cm 2 to 1000 mJ/cm 2 . When a general liquid crystal alignment agent is used, the light irradiation dose for the alignment treatment is 100 mJ/cm 2 to 5000 mJ/cm 2 , but the liquid crystal alignment agent of the present invention can still obtain a liquid crystal alignment film in which the variation (non-uniformity) of the liquid crystal alignment within the film surface is effectively suppressed even if the light irradiation dose for the alignment treatment is reduced. When irradiating radiation, in order to improve the liquid crystal alignment, the substrate of the aforementioned film-like object can be heated at 50°C to 250°C while irradiating. The liquid crystal alignment film produced in this way can make the liquid crystal molecules align stably in a certain direction. Secondly, the liquid crystal alignment film irradiated with polarized radiation in the aforementioned method can be contact-treated with a solvent, or the liquid crystal alignment film irradiated with radiation can be heated.
前述接觸處理所使用之溶劑沒有特別之限制,其僅須可溶解經放射線照射後,從膜狀物所生成之分解物即可。具體例可列舉水、甲醇、乙醇、2-丙醇、丙酮、甲乙酮、1-甲氧基-2-丙醇、1-甲氧基-2-丙醇乙酸酯、丁基賽珞蘇、乳酸乙酯、乳酸甲酯、二丙酮醇、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、乙酸丙酯、乙酸丁酯,或乙酸環己酯等。其中,基於泛用性與安全性之觀點,較佳為水、2-丙醇、1-甲氧基-2-丙醇或乳酸乙酯,且更佳為水、1-甲氧基-2-丙醇或乳酸乙酯。溶劑可單獨一種使用或混合複數種使用。There is no particular limitation on the solvent used in the aforementioned contact treatment, and it only needs to be able to dissolve the decomposition products generated from the film after irradiation with radiation. Specific examples include water, methanol, ethanol, 2-propanol, acetone, methyl ethyl ketone, 1-methoxy-2-propanol, 1-methoxy-2-propanol acetate, butyl celoxylate, ethyl lactate, methyl lactate, diacetone alcohol, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, propyl acetate, butyl acetate, or cyclohexyl acetate. Among them, based on the viewpoint of versatility and safety, water, 2-propanol, 1-methoxy-2-propanol or ethyl lactate are preferred, and water, 1-methoxy-2-propanol or ethyl lactate are more preferred. The solvent can be used alone or in combination.
對前述已照射放射線之塗膜進行加熱處理的溫度較佳為50℃至300℃,且更佳為120℃至250℃。加熱處理之時間較佳為1分鐘至30分鐘。The temperature for heat treatment of the coating film irradiated with radiation is preferably 50° C. to 300° C., and more preferably 120° C. to 250° C. The time for heat treatment is preferably 1 minute to 30 minutes.
步驟(4):製作液晶胞Step (4): Making liquid crystal cells
準備兩片前述所形成之液晶配向膜基板,並於面向配置之兩片基板間配置液晶。舉例而言,可列舉下述之兩種方法。第一種方法,首先以各液晶配向膜面對的方式,隔著間隙(晶胞間隙)將兩片基板面向配置。然後,將兩片基板之周邊部以密封劑貼合,再將液晶組成物注入填充至由基板表面及密封劑區隔出的晶胞間隙內,並於其接觸膜面後,密封注入孔。Prepare two substrates with the liquid crystal alignment films formed above, and arrange the liquid crystal between the two substrates facing each other. For example, the following two methods can be listed. The first method is to arrange the two substrates facing each other with a gap (cell gap) between them in a way that the liquid crystal alignment films face each other. Then, the periphery of the two substrates is bonded with a sealant, and then the liquid crystal composition is injected into the cell gap separated by the substrate surface and the sealant, and after it contacts the film surface, the injection hole is sealed.
第二種方法,係稱為ODF(液晶滴入式封填;One Drop Fill)之方法。在已形成液晶配向膜之兩片基板中的其中一者之預定位置塗佈如紫外光硬化性之密封劑,再於液晶配向膜面上之多個預定位置滴加液晶組成物。然後,以液晶配向膜相面對的方式貼合另一基板,而將液晶組成物推壓在基板之整面,使其接觸膜面。接著,對基板整面照射紫外光,以使密封劑硬化。依進行前述之任一方法時,較佳係進一步將所使用之液晶組成物加熱至成為等向相的溫度後,緩慢放冷到室溫,以去除液晶填充時之流動配向。其次,對塗膜實施摩擦處理時,兩片基板係以各塗膜之摩擦方向互相成預定角度來面向配置,例如成直交或反向平行之方式。密封劑可例如為含有硬化劑及作為間隔件之氧化鋁球的環氧樹脂等。液晶組成物可列舉向列型液晶及層列型液晶,且較佳為向列型液晶。The second method is called ODF (One Drop Fill). A sealant such as a UV-curable sealant is applied to a predetermined position on one of the two substrates on which a liquid crystal alignment film has been formed, and then a liquid crystal composition is dripped onto a plurality of predetermined positions on the surface of the liquid crystal alignment film. Then, the other substrate is bonded with the liquid crystal alignment films facing each other, and the liquid crystal composition is pushed onto the entire surface of the substrate so that it contacts the film surface. Next, ultraviolet light is irradiated onto the entire surface of the substrate to cure the sealant. When performing any of the aforementioned methods, it is preferred to further heat the liquid crystal composition used to a temperature at which it becomes an isotropic phase, and then slowly cool it to room temperature to remove the flow alignment during liquid crystal filling. Secondly, when the coating is subjected to rubbing treatment, the two substrates are arranged so that the rubbing directions of the coatings are at a predetermined angle to each other, for example, perpendicular or anti-parallel. The sealant may be, for example, an epoxy resin containing a hardener and aluminum oxide balls as spacers. The liquid crystal composition may be nematic liquid crystal and lamellar liquid crystal, and preferably nematic liquid crystal.
視需要可於液晶胞之外側表面貼合偏光板,以獲得液晶顯示元件。液晶胞之外表面所貼合之偏光板可列舉延伸配向聚乙烯醇並同時吸收碘,且稱為「H膜」的偏光薄膜。其可為以乙酸纖維素保護膜所夾持而成之偏光板,或者H膜本身所構成之偏光板。If necessary, a polarizing plate can be attached to the outer surface of the liquid crystal cell to obtain a liquid crystal display element. The polarizing plate attached to the outer surface of the liquid crystal cell can be a polarizing film called "H film" that stretches polyvinyl alcohol and absorbs iodine at the same time. It can be a polarizing plate sandwiched by a cellulose acetate protective film, or a polarizing plate composed of the H film itself.
以下利用實施例以說明本發明之應用,然其並非用以限定本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾。The following embodiments are used to illustrate the application of the present invention, but they are not used to limit the present invention. Anyone skilled in the art can make various changes and modifications without departing from the spirit and scope of the present invention.
製備二胺化合物(a2-1)Preparation of diamine compound (a2-1)
合成例a2-1-1Synthesis Example a2-1-1
將27.39克(0.18莫耳)的1-苯基-1,3-丙二醇與14.2克(0.18莫耳)吡啶混合,然後將混合物溶解在60克的甲苯中,並加入85.08克(0.54莫耳)的4-硝基氯苯從而形成反應溶液。 將該反應溶液在25℃下反應6小時。 然後將反應溶液與200 ml純水混合,並進行純化和濃縮,以獲得固體產物。之後,固體產物使用甲醇進行結晶,從而形成合成例a2-1-1的粉末狀中間產物。27.39 g (0.18 mol) of 1-phenyl-1,3-propanediol was mixed with 14.2 g (0.18 mol) of pyridine, and the mixture was dissolved in 60 g of toluene, and 85.08 g (0.54 mol) of 4-nitrochlorobenzene was added to form a reaction solution. The reaction solution was reacted at 25° C. for 6 hours. The reaction solution was then mixed with 200 ml of pure water, purified and concentrated to obtain a solid product. Thereafter, the solid product was crystallized using methanol to form a powdery intermediate product of Synthesis Example a2-1-1.
接著,將前述之中間產物溶解於40克的甲苯中。保持溶液溫度為5℃,將0.02克10%的鈀碳(Pd-C)作為催化劑加入到溶液中,並緩慢滴加4.8克的肼,然後在165℃下反應。反應8小時後,將反應溶液與100 ml的水混合,並進行純化和濃縮,以獲得固體產物。之後,固體產物使用甲醇進行結晶。收集所得到的粉末狀產物,並以甲苯進行再結晶,即可獲得如式(A21-2)所示之合成例a2-1-1的白色粉末產物。Next, the aforementioned intermediate product is dissolved in 40 grams of toluene. Keeping the solution temperature at 5°C, 0.02 grams of 10% palladium carbon (Pd-C) is added to the solution as a catalyst, and 4.8 grams of hydrazine is slowly added dropwise, and then reacted at 165°C. After reacting for 8 hours, the reaction solution is mixed with 100 ml of water, purified and concentrated to obtain a solid product. Thereafter, the solid product is crystallized using methanol. The obtained powdery product is collected and recrystallized with toluene to obtain the white powder product of Synthesis Example a2-1-1 as shown in Formula (A21-2).
合成例a2-1-2至合成例a2-1-6Synthesis Example a2-1-2 to Synthesis Example a2-1-6
合成例a2-1-2至合成例a2-1-6使用與合成例2-1-1之二胺化合物(a2-1)的製作方法相同之製備方法,不同之處在於合成例a2-1-2至合成例a2-1-6係如下述改變反應物的種類。Synthesis Examples a2-1-2 to a2-1-6 use the same preparation method as the preparation method of the diamine compound (a2-1) in Synthesis Example 2-1-1, except that Synthesis Examples a2-1-2 to a2-1-6 change the type of reactants as described below.
合成例a2-1-2係使用2-環己基-1,4-丁二醇取代1-苯基-1,3-丙二醇,並使用對氟硝基苯取代4-硝基氯苯,且所製得之產物具有如式(A21-3)所示之結構。In synthesis example a2-1-2, 2-cyclohexyl-1,4-butanediol is used to replace 1-phenyl-1,3-propanediol, and p-fluoronitrobenzene is used to replace 4-nitrochlorobenzene, and the obtained product has a structure shown in formula (A21-3).
合成例a2-1-3係使用2-正戊基-1,4-丁二醇取代1-苯基-1,3-丙二醇,且所製得之產物具有如式(A21-5)所示之結構。In synthesis example a2-1-3, 2-n-pentyl-1,4-butanediol is used to replace 1-phenyl-1,3-propanediol, and the obtained product has a structure as shown in formula (A21-5).
合成例a2-1-4係使用6-甲基-1,4-庚二醇取代1-苯基-1,3-丙二醇,並使用對氟硝基苯取代4-硝基氯苯,且所製得之產物具有如式(A21-7)所示之結構。In synthesis example a2-1-4, 6-methyl-1,4-heptanediol is used to replace 1-phenyl-1,3-propanediol, and p-fluoronitrobenzene is used to replace 4-nitrochlorobenzene, and the obtained product has a structure shown in formula (A21-7).
合成例a2-1-5係使用1,2-丙二醇取代1-苯基-1,3-丙二醇,並使用對氟硝基苯取代4-硝基氯苯,且所製得之產物具有如式(A21-8)所示之結構。In synthesis example a2-1-5, 1,2-propylene glycol is used to replace 1-phenyl-1,3-propylene glycol, and p-fluoronitrobenzene is used to replace 4-nitrochlorobenzene, and the obtained product has a structure shown in formula (A21-8).
合成例a2-1-6係使用2-乙基-1,3-丙二醇取代1-苯基-1,3-丙二醇,且所製得之產物具有如式(A21-9)所示之結構。In synthesis example a2-1-6, 2-ethyl-1,3-propanediol is used to replace 1-phenyl-1,3-propanediol, and the obtained product has a structure as shown in formula (A21-9).
製備聚合物(A)Preparation of polymer (A)
合成例A-1-1Synthesis Example A-1-1
在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入1.355克(0.00525莫耳)的合成例a2-1-5所製得的二胺化合物(a2-1-5)、1.764克(0.00525莫耳)的如式(A22-7)所示之二胺化合物(a2-2-1)與3.042克 (0.0045莫耳)的二胺化合物(a2-3-1)及80克的N-甲基-2-吡咯烷酮(以下簡稱NMP),並於室溫下攪拌至溶解。接著,加入3.36克(0.015莫耳)的化合物(a1-1-1)及20克的NMP,並於室溫下反應2小時。反應結束後,將反應溶液倒入1500毫升的水中,以析出聚合物,過濾所得之聚合物,並以甲醇重複進行清洗及過濾之步驟三次。之後,將產物置入真空烘箱中,並以溫度60℃進行乾燥,即可製得合成例A-1-1之聚合物(A-1-1),其配方如第1表所示。A nitrogen inlet, a stirrer, a condenser and a thermometer were installed on a 500 ml four-necked conical flask, and nitrogen was introduced. Then, 1.355 g (0.00525 mol) of the diamine compound (a2-1-5) obtained in Synthesis Example a2-1-5, 1.764 g (0.00525 mol) of the diamine compound (a2-2-1) represented by formula (A22-7), 3.042 g (0.0045 mol) of the diamine compound (a2-3-1) and 80 g of N-methyl-2-pyrrolidone (hereinafter referred to as NMP) were added, and stirred at room temperature until dissolved. Then, 3.36 g (0.015 mol) of the compound (a1-1-1) and 20 g of NMP were added, and the mixture was reacted at room temperature for 2 hours. After the reaction is completed, the reaction solution is poured into 1500 ml of water to precipitate the polymer, and the obtained polymer is filtered and washed and filtered with methanol three times. After that, the product is placed in a vacuum oven and dried at a temperature of 60°C to obtain the polymer (A-1-1) of Synthesis Example A-1-1, whose formula is shown in Table 1.
合成例A-1-2至合成例A-1-20與比較合成例A-1-21至比較合成例A-1-26Synthesis Examples A-1-2 to A-1-20 and Comparative Synthesis Examples A-1-21 to A-1-26
合成例A-1-2至合成例A-1-20與比較合成例A-1-21至比較合成例A-1-26使用與合成例A-1-1之聚合物(A-1-1)的製作方法相同之製備方法,不同之處在於合成例A-1-2至合成例A-1-20與比較合成例A-1-21至比較合成例A-1-26改變聚合物中原料的種類與使用量,其配方如第1表所示,此處不另贅述。Synthesis Examples A-1-2 to A-1-20 and Comparative Synthesis Examples A-1-21 to A-1-26 use the same preparation method as the preparation method of the polymer (A-1-1) in Synthesis Example A-1-1. The difference is that Synthesis Examples A-1-2 to A-1-20 and Comparative Synthesis Examples A-1-21 to A-1-26 change the types and usage amounts of raw materials in the polymers. The formulas are shown in Table 1 and are not described in detail here.
合成例A-2-1Synthesis Example A-2-1
在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入1.355克(0.00525莫耳)的合成例a2-1-5所製得的二胺化合物(a2-1-5)、1.764克(0.00525莫耳)的如式(A22-7)所示之二胺化合物(a2-2-1)與3.042克(0.0045莫耳)的二胺化合物(a2-3-1)及80克的N-甲基-2-吡咯烷酮(以下簡稱NMP),並於室溫下攪拌至溶解。接著,加入3.36克(0.015莫耳)的化合物(a1-1-1)及20克的NMP。於室溫下反應6小時後,加入97克的NMP、2.55克的醋酸酐及19.75克的吡啶,升溫至60℃,且持續攪拌2小時,以進行醯亞胺化反應。待反應結束後,將反應溶液倒入1500毫升水中,以使聚合物析出。然後,過濾所得的聚合物,並重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,即可製得聚合物(A-2-1),其配方如第1表所示。A nitrogen inlet, a stirrer, a condenser and a thermometer were installed on a 500 ml four-necked conical flask, and nitrogen was introduced. Then, 1.355 g (0.00525 mol) of the diamine compound (a2-1-5) obtained in Synthesis Example a2-1-5, 1.764 g (0.00525 mol) of the diamine compound (a2-2-1) represented by formula (A22-7), 3.042 g (0.0045 mol) of the diamine compound (a2-3-1) and 80 g of N-methyl-2-pyrrolidone (hereinafter referred to as NMP) were added, and stirred at room temperature until dissolved. Then, 3.36 g (0.015 mol) of the compound (a1-1-1) and 20 g of NMP were added. After reacting at room temperature for 6 hours, 97 g of NMP, 2.55 g of acetic anhydride and 19.75 g of pyridine were added, the temperature was raised to 60°C, and stirring was continued for 2 hours to carry out the imidization reaction. After the reaction was completed, the reaction solution was poured into 1500 ml of water to precipitate the polymer. Then, the obtained polymer was filtered, and washed and filtered with methanol three times repeatedly, placed in a vacuum oven, and dried at a temperature of 60°C to obtain polymer (A-2-1), the formula of which is shown in Table 1.
合成例A-2-2至合成例A-2-4Synthesis Example A-2-2 to Synthesis Example A-2-4
合成例A-2-2至合成例A-2-4使用與合成例A-2-1之聚合物(A-2-1)的製作方法相同之製備方法,不同之處在於合成例A-2-2至合成例A-2-4改變聚合物中原料的種類與使用量,其配方如第1表所示,此處不另贅述。Synthesis Examples A-2-2 to A-2-4 use the same preparation method as the preparation method of the polymer (A-2-1) in Synthesis Example A-2-1. The difference is that Synthesis Examples A-2-2 to A-2-4 change the type and amount of raw materials in the polymer. The formula is shown in Table 1 and is not further described here.
製備聚合物(B)Preparation of polymer (B)
合成例B-1-1至合成例B-1-3Synthesis Example B-1-1 to Synthesis Example B-1-3
合成例B-1-1至合成例B-1-3係使用與合成例A-1-1之聚合物(A-1-1)的製作方法相同之製備方法,不同之處在於合成例B-1-1至合成例B-1-3改變聚合物物中原料的種類與使用量。其配方分別如第2表所示,此處不另贅述。Synthesis Examples B-1-1 to B-1-3 use the same preparation method as the preparation method of the polymer (A-1-1) of Synthesis Example A-1-1, except that the types and amounts of raw materials used in the polymers are changed in Synthesis Examples B-1-1 to B-1-3. The formulas are shown in Table 2 and are not described here.
合成例B-2-1至合成例B-2-3Synthesis Example B-2-1 to Synthesis Example B-2-3
合成例B-2-1至合成例B-2-3係使用與合成例A-2-1之聚合物(A-2-1)的製作方法相同之製備方法,不同之處在於合成例B-2-1至合成例B-2-3改變聚合物物中原料的種類與使用量。其配方分別如第2表所示,此處不另贅述。Synthesis Examples B-2-1 to B-2-3 use the same preparation method as the preparation method of the polymer (A-2-1) of Synthesis Example A-2-1, except that the types and amounts of raw materials used in the polymers are changed in Synthesis Examples B-2-1 to B-2-3. The formulas are shown in Table 2 and are not described here.
製備液晶配向劑、液晶配向膜及液晶顯示元件Preparation of liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
實施例1Embodiment 1
秤取50重量份之合成例A-1-1所製得的聚合物(A-1-1)、50重量份之合成例B-1-1所製得的聚合物(B-1-1)與1600重量份之NMP(C-1),並於室溫下攪拌混合,即可製得實施例1之液晶配向劑。Weigh 50 parts by weight of the polymer (A-1-1) prepared in Synthesis Example A-1-1, 50 parts by weight of the polymer (B-1-1) prepared in Synthesis Example B-1-1, and 1600 parts by weight of NMP (C-1), and stir and mix them at room temperature to prepare the liquid crystal alignment agent of Example 1.
將前述所製得的液晶配向劑旋轉塗佈在玻璃基板上,且玻璃基板上形成有畫素電極,其中畫素電極為具有一對ITO電極(電極寬為10 μm,電極間隔為10 μm,而電極高度為50 nm)之IPS驅動用電極,該對ITO電極係分別具有櫛齒狀之形狀,且彼此之櫛齒狀部份係以分開並咬合之方式來配置。然後,將塗佈有液晶配向劑的玻璃基板在80℃的加熱板上乾燥3分鐘後,在250℃之熱風循環式烘箱中烘烤30分鐘,即可形成膜厚為100 nm的塗膜。The liquid crystal alignment agent prepared above is applied on a glass substrate by rotation, and a pixel electrode is formed on the glass substrate, wherein the pixel electrode is an IPS driving electrode having a pair of ITO electrodes (electrode width is 10 μm, electrode spacing is 10 μm, and electrode height is 50 nm). The pair of ITO electrodes are respectively in a comb-shaped shape, and the comb-shaped parts of each other are configured in a separated and interlocking manner. Then, the glass substrate coated with the liquid crystal alignment agent is dried on a heating plate at 80°C for 3 minutes, and then baked in a hot air circulation oven at 250°C for 30 minutes to form a coating with a film thickness of 100 nm.
透過一偏光板,對塗膜面照射波長為254 nm的紫外線後,在250℃之熱風循環式烘箱中烘烤30分鐘,以製得具有液晶配向膜的基板。同樣地,在對向基板上形成塗膜並施予配向處理,所述對向基板為未有電極形成的但具有高度為4 μm之柱狀間隔件的玻璃基板。After irradiating the coated surface with ultraviolet light of 254 nm through a polarizing plate, the substrate was baked in a hot air circulation oven at 250°C for 30 minutes to obtain a substrate with a liquid crystal alignment film. Similarly, a coating was formed on an opposing substrate and an alignment treatment was applied. The opposing substrate was a glass substrate without an electrode but with a columnar spacer of 4 μm in height.
上述二個基板為一組,在其中一者上印刷密封劑,而另一者以與液晶配向膜面對且配向方向為0°的方式,黏合二者,之後硬化密封劑以製得空的晶胞。將這個空晶胞以減壓注入法,注入液晶MLC-2041(Merck公司製),並密封注入口,即可製得實施例1之液晶顯示元件。所得之液晶顯示元件以下列之評價方式進行評價,其結果如第3表所示,其中畫素內對比變異度的檢測方法容後再述。The above two substrates are a set, and a sealant is printed on one of them, and the other is bonded in a manner that it faces the liquid crystal alignment film and the alignment direction is 0°, and then the sealant is hardened to produce an empty cell. This empty cell is injected with liquid crystal MLC-2041 (Merck) by a reduced pressure injection method, and the injection port is sealed to produce the liquid crystal display element of Example 1. The obtained liquid crystal display element is evaluated by the following evaluation method, and the results are shown in Table 3, among which the detection method of the contrast variation within the pixel will be described later.
實施例2至實施例28與比較例1至比較例6Examples 2 to 28 and Comparative Examples 1 to 6
實施例2至實施例28與比較例1至比較例6係使用與實施例1之液晶配向劑、液晶配向膜及液晶顯示元件相同之製備方法,不同之處在於實施例2至實施例28與比較例1至比較例6係改變液晶配向劑中原料的種類及使用量,其配方及評價結果分別如第3表所示,此處不另贅述。Examples 2 to 28 and Comparative Examples 1 to 6 use the same preparation method of the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element as Example 1. The difference is that Examples 2 to 28 and Comparative Examples 1 to 6 change the type and usage of raw materials in the liquid crystal alignment agent. Their formulas and evaluation results are shown in Table 3, which will not be described in detail here.
評價方式Evaluation method
畫素內對比變異度 Intra-pixel contrast variation
使用AXOMETRICS公司製作,且型號為AxoStep的設備來量測液晶顯示元件的扭轉角變化。將前述實施例與比較例所製得之液晶顯示元件置於測量台上,且在不施加電壓的情形下量測畫素內之圓延遲(Circular Retardance)的分布,計算標準偏差(σ)的3倍值(3σ)。其中,標準偏差的3倍值(3σ)越小,畫素內對比變異度越低,且畫素內對比變異度以下述之基準進行評價。 ※:3σ≦2。 ◎:2<3σ≦3。 ○:3<3σ≦4。 △:4<3σ≦5。 ╳:3σ>5。 The torsion angle variation of the liquid crystal display element was measured using an AxoStep device manufactured by AXOMETRICS. The liquid crystal display element manufactured by the aforementioned embodiment and comparative example was placed on a measuring table, and the distribution of the circular retardance in the pixel was measured without applying voltage, and the 3 times value (3σ) of the standard deviation (σ) was calculated. Among them, the smaller the 3 times value (3σ) of the standard deviation, the lower the contrast variation in the pixel, and the contrast variation in the pixel was evaluated according to the following criteria. ※: 3σ≦2. ◎: 2<3σ≦3. ○: 3<3σ≦4. △: 4<3σ≦5. ╳: 3σ>5.
由第3表之結果可知,若本發明之液晶配向劑之二胺組份(a2)不包含如式(A21)所示之二胺化合物(a2-1)時,含有利用此液晶配向劑所製得之液晶配向膜的液晶顯示元件將具有較高的畫素內對比變異度。其中,當式(A21)中之Y 11代表碳數為1至5之脂肪族鏈狀烴基時,所製得之液晶顯示元件將具有較低的畫素內對比變異度。當式(A21)中之Y 11代表碳數為1至3之飽和直鏈烴基時,所製得之液晶顯示元件將具有更低的畫素內對比變異度。再者,當二胺組份(a2)包含如式(A22)所示之二胺化合物(a2-2)時,所製得之液晶配向劑將使所形成之液晶顯示元件具有較低的畫素內對比變異度。當四羧酸衍生物組份(a1)包含如式(A11)所示之脂環族四羧酸二酐化合物(a1-1),且式(A11)之X 1代表上式(A11-1-1)所示之結構,含有其所形成之液晶配向膜的液晶顯示單元具有更低之畫素內對比變異度。 From the results of Table 3, it can be seen that if the diamine component (a2) of the liquid crystal alignment agent of the present invention does not contain the diamine compound (a2-1) as shown in formula (A21), the liquid crystal display element containing the liquid crystal alignment film prepared using this liquid crystal alignment agent will have a higher intra-pixel contrast variability. Among them, when Y 11 in formula (A21) represents an aliphatic chain hydrocarbon group with a carbon number of 1 to 5, the resulting liquid crystal display element will have a lower intra-pixel contrast variability. When Y 11 in formula (A21) represents a saturated linear hydrocarbon group with a carbon number of 1 to 3, the resulting liquid crystal display element will have an even lower intra-pixel contrast variability. Furthermore, when the diamine component (a2) comprises a diamine compound (a2-2) as shown in formula (A22), the liquid crystal alignment agent prepared will make the formed liquid crystal display element have a lower contrast variation within the pixel. When the tetracarboxylic acid derivative component (a1) comprises an alicyclic tetracarboxylic dianhydride compound (a1-1) as shown in formula (A11), and X1 in formula (A11) represents the structure shown in formula (A11-1-1), the liquid crystal display unit containing the liquid crystal alignment film formed therefrom has a lower contrast variation within the pixel.
需補充的是,本發明雖以特定的化合物、組成、反應條件、製程、分析方法或特定儀器作為例示,說明本發明之液晶配向劑、液晶配向膜與液晶顯示元件,惟本發明所屬技術領域中任何具有通常知識者可知,本發明並不限於此,在不脫離本發明之精神和範圍內,本發明之液晶配向劑、液晶配向膜與液晶顯示元件亦可使用其他的化合物、組成、反應條件、製程、分析方法或儀器進行。It should be added that, although the present invention uses specific compounds, compositions, reaction conditions, processes, analysis methods or specific instruments as examples to illustrate the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element of the present invention, anyone with common knowledge in the technical field to which the present invention belongs can know that the present invention is not limited to these. Without departing from the spirit and scope of the present invention, the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element of the present invention can also use other compounds, compositions, reaction conditions, processes, analysis methods or instruments.
雖然本發明已以實施方式揭露如上,然其並非用以限定本發明,在本發明所屬技術領域中任何具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。Although the present invention has been disclosed in the above embodiments, it is not intended to limit the present invention. Anyone with ordinary knowledge in the technical field to which the present invention belongs can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the scope defined in the attached patent application.
(無)(without)
(無)(without)
國內寄存資訊(請依寄存機構、日期、號碼順序註記) 無 國外寄存資訊(請依寄存國家、機構、日期、號碼順序註記) 無 Domestic storage information (please note in the order of storage institution, date, and number) None Foreign storage information (please note in the order of storage country, institution, date, and number) None
(無)(without)
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202411324389.5A CN119717338A (en) | 2023-09-26 | 2024-09-23 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW112136840 | 2023-09-26 | ||
| TW112136840 | 2023-09-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TWI863615B true TWI863615B (en) | 2024-11-21 |
| TW202513773A TW202513773A (en) | 2025-04-01 |
Family
ID=94379963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112138609A TWI863615B (en) | 2023-09-26 | 2023-10-06 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN119717338A (en) |
| TW (1) | TWI863615B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201902985A (en) * | 2017-06-13 | 2019-01-16 | 奇美實業股份有限公司 | Method for manufacturing liquid crystal alignment film and liquid crystal display element |
| TW202204478A (en) * | 2020-06-26 | 2022-02-01 | 日商日產化學股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| TW202321428A (en) * | 2021-08-06 | 2023-06-01 | 日商日產化學股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
-
2023
- 2023-10-06 TW TW112138609A patent/TWI863615B/en active
-
2024
- 2024-09-23 CN CN202411324389.5A patent/CN119717338A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201902985A (en) * | 2017-06-13 | 2019-01-16 | 奇美實業股份有限公司 | Method for manufacturing liquid crystal alignment film and liquid crystal display element |
| TW202204478A (en) * | 2020-06-26 | 2022-02-01 | 日商日產化學股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| TW202321428A (en) * | 2021-08-06 | 2023-06-01 | 日商日產化學股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
Also Published As
| Publication number | Publication date |
|---|---|
| CN119717338A (en) | 2025-03-28 |
| TW202513773A (en) | 2025-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022176680A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI863615B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI888820B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI901102B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI865340B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI897382B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI892269B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI900100B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI887964B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI859005B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI905717B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI911714B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI890820B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI902144B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI906749B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI903532B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI906999B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TW202544129A (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| CN120829782A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element for photo-alignment method | |
| TW202542286A (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TW202538041A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TW202542287A (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| WO2025121249A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
| TW202436598A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| JP2026001186A (en) | Polymer composition, liquid crystal alignment agent, resin film, liquid crystal alignment film, method for producing liquid crystal display element, and liquid crystal display element |